<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">97662</article-id><article-id pub-id-type="doi">10.7554/eLife.97662</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.97662.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Muscle-resident mesenchymal progenitors sense and repair peripheral nerve injury via the GDNF-BDNF axis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yoo</surname><given-names>Kyusang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9852-5344</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jo</surname><given-names>Young-Woo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yoo</surname><given-names>Takwon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0000-4381-7553</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hann</surname><given-names>Sang-Hyeon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0871-3414</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Inkuk</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Yea-Eun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ye Lynne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rhee</surname><given-names>Joonwoo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>In-Wook</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ji-Hoon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Baek</surname><given-names>Daehyun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kong</surname><given-names>Young-Yun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7335-3729</contrib-id><email>ykong@snu.ac.kr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>School of Biological Sciences, Seoul National University</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05kzfa883</institution-id><institution>Molecular Recognition Research Center, Korea Institute of Science and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005dvqh91</institution-id><institution>New York University Langone Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>26</day><month>09</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP97662</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-03-25"><day>25</day><month>03</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-03-27"><day>27</day><month>03</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.03.25.586563"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-06-04"><day>04</day><month>06</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97662.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-20"><day>20</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97662.2"/></event></pub-history><permissions><copyright-statement>Â© 2024, Yoo et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Yoo et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-97662-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-97662-figures-v1.pdf"/><abstract><p>Fibro-adipogenic progenitors (FAPs) are muscle-resident mesenchymal progenitors that can contribute to muscle tissue homeostasis and regeneration, as well as postnatal maturation and lifelong maintenance of the neuromuscular system. Recently, traumatic injury to the peripheral nerve was shown to activate FAPs, suggesting that FAPs can respond to nerve injury. However, questions of how FAPs can sense the anatomically distant peripheral nerve injury and whether FAPs can directly contribute to nerve regeneration remained unanswered. Here, utilizing single-cell transcriptomics and mouse models, we discovered that a subset of FAPs expressing GDNF receptors <italic>Ret</italic> and <italic>Gfra1</italic> can respond to peripheral nerve injury by sensing GDNF secreted by Schwann cells. Upon GDNF sensing, this subset becomes activated and expresses <italic>Bdnf</italic>. FAP-specific inactivation of <italic>Bdnf</italic> (<italic>Prrx1<sup>Cre</sup>; Bdnf<sup>fl/fl</sup></italic>) resulted in delayed nerve regeneration owing to defective remyelination, indicating that GDNF-sensing FAPs play an important role in the remyelination process during peripheral nerve regeneration. In aged mice, significantly reduced <italic>Bdnf</italic> expression in FAPs was observed upon nerve injury, suggesting the clinical relevance of FAP-derived BDNF in the age-related delays in nerve regeneration. Collectively, our study revealed the previously unidentified role of FAPs in peripheral nerve regeneration, and the molecular mechanism behind FAPsâ response to peripheral nerve injury.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>fibro-adipogenic progenitor</kwd><kwd>single-cell RNA-sequencing</kwd><kwd>schwann cell myelination</kwd><kwd>peripheral nerve injury</kwd><kwd>GDNF</kwd><kwd>BDNF</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2020R1A5A1018081</award-id><principal-award-recipient><name><surname>Yoo</surname><given-names>Kyusang</given-names></name><name><surname>Jo</surname><given-names>Young-Woo</given-names></name><name><surname>Hann</surname><given-names>Sang-Hyeon</given-names></name><name><surname>Park</surname><given-names>Inkuk</given-names></name><name><surname>Kim</surname><given-names>Yea-Eun</given-names></name><name><surname>Kim</surname><given-names>Ye Lynne</given-names></name><name><surname>Rhee</surname><given-names>Joonwoo</given-names></name><name><surname>Song</surname><given-names>In-Wook</given-names></name><name><surname>Kong</surname><given-names>Young-Yun</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2022R1A2C3007621</award-id><principal-award-recipient><name><surname>Yoo</surname><given-names>Kyusang</given-names></name><name><surname>Jo</surname><given-names>Young-Woo</given-names></name><name><surname>Hann</surname><given-names>Sang-Hyeon</given-names></name><name><surname>Park</surname><given-names>Inkuk</given-names></name><name><surname>Kim</surname><given-names>Yea-Eun</given-names></name><name><surname>Kim</surname><given-names>Ye Lynne</given-names></name><name><surname>Rhee</surname><given-names>Joonwoo</given-names></name><name><surname>Song</surname><given-names>In-Wook</given-names></name><name><surname>Kong</surname><given-names>Young-Yun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>GDNF receptor-expressing mesenchymal progenitor subpopulation within skeletal muscle responds to peripheral nerve injury by sensing GDNF and secreting BDNF, thereby directly promoting nerve regeneration through facilitating remyelination by Schwann cells.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Positioned in the interstitial space between myofibers (<xref ref-type="bibr" rid="bib77">Uezumi et al., 2010</xref>), fibro-adipogenic progenitors (FAPs) interact with cellular components within a skeletal muscle to ensure normal development, homeostasis, and regeneration of muscle tissue. During developmental myogenesis, embryonic FAPs expressing <italic>Osr1</italic> contribute to limb muscle patterning by regulating the expression of extracellular matrix (ECM) genes that makeup muscle connective tissue (<xref ref-type="bibr" rid="bib81">Vallecillo-GarcÃ­a et al., 2017</xref>). In young adults, FAPs are necessary for normal growth and long-term maintenance of skeletal muscle, which otherwise undergo progressive muscle atrophy in the absence of PDGFRÎ±<sup>+</sup> FAPs (<xref ref-type="bibr" rid="bib65">Roberts et al., 2013</xref>; <xref ref-type="bibr" rid="bib85">Wosczyna et al., 2019</xref>; <xref ref-type="bibr" rid="bib80">Uezumi et al., 2021</xref>). Upon muscle injury, FAPs proliferate in response to IL-4/IL-13 signals from eosinophils, and participate in the clearing of necrotic debris via phagocytosis (<xref ref-type="bibr" rid="bib28">Heredia et al., 2013</xref>). Also, the proliferated FAPs regulate the expansion and asymmetric commitment of muscle stem cells (MuSCs) via secreted factors such as WISP1, leading to robust de novo myofiber formation (<xref ref-type="bibr" rid="bib31">Joe et al., 2010</xref>; <xref ref-type="bibr" rid="bib47">Lukjanenko et al., 2019</xref>; <xref ref-type="bibr" rid="bib85">Wosczyna et al., 2019</xref>). Conversely, the absence of FAPs or its functional decline with age cause premature differentiation of MuSCs upon injury, resulting in the formation of smaller regenerated myofibers (<xref ref-type="bibr" rid="bib55">Murphy et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Lukjanenko et al., 2019</xref>; <xref ref-type="bibr" rid="bib85">Wosczyna et al., 2019</xref>). After sufficient regeneration of myofibers occurs, FAPs undergo apoptosis via TNF signaling from monocyte/macrophages, such that its numbers return to those of unperturbed muscles (<xref ref-type="bibr" rid="bib42">Lemos et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Saito et al., 2020</xref>). Failure to remove excess FAPs after muscle regeneration results in unwanted fibrosis, which compromises muscle function (<xref ref-type="bibr" rid="bib78">Uezumi et al., 2011</xref>; <xref ref-type="bibr" rid="bib79">Uezumi et al., 2014</xref>).</p><p>In addition to the formation and maintenance of muscle tissue, FAPs also contribute to the maturation and maintenance of the neural components within skeletal muscle. Previously, we reported that FAPs promote postsynaptic maturation of the neuromuscular junction (NMJ) through the BAP1/SMN axis during postnatal development (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>). Selective inactivation of <italic>Bap1</italic> in FAPs results in dysfunctional NMJs, with sustained expression of the immature form of acetylcholine receptor subunit, <italic>AchRÎ³</italic>, in skeletal muscle (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>). Progressively, these mice exhibit denervation at the NMJ, retraction of motor axons, reduction of myelination and axon diameter, and eventually motor neuron loss, suggesting that FAPs prevent the dying-back loss of motor neurons (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>). Recently, we also reported defective presynaptic maturation and maintenance in mice with selective <italic>Smn</italic> downregulation in FAPs, again suggesting the role of FAPs in postnatal NMJ development (<xref ref-type="bibr" rid="bib25">Hann et al., 2024</xref>). In adult mice, BMP3B secretion by FAPs stabilize NMJs and Schwann cells by promoting the myelination program in Schwann cells, thereby directly contributing to the maintenance of neural components within skeletal muscle (<xref ref-type="bibr" rid="bib80">Uezumi et al., 2021</xref>). In the absence of FAPs or <italic>Bmp3b</italic>, mice exhibit muscle weakness and myofiber atrophy along with destabilization of Schwann cells and denervation at NMJs, which closely resemble the phenotypes observed in age-related sarcopenia (<xref ref-type="bibr" rid="bib80">Uezumi et al., 2021</xref>). Similarly, conditional deletion of <italic>Bap1</italic> in FAPs in adulthood cause denervation at the NMJs and eventually loss of motor neurons, demonstrating the requirement of FAPs in maintaining the neuromuscular system (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>). Conversely, disturbance in the neural component can influence the behavior of FAPs; for instance, denervation is known to activate FAPs (<xref ref-type="bibr" rid="bib11">Contreras et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Gonzalez et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Madaro et al., 2018</xref>). This suggests that FAPs can somehow sense the anatomically distant peripheral nerve injury. However, the question of how FAPs are able to sense the distant peripheral nerve injury remains unanswered (<xref ref-type="bibr" rid="bib73">Theret et al., 2021</xref>). Furthermore, whether FAPs are actually able to exert beneficial effects on peripheral nerve regeneration remains elusive.</p><p>In accordance with its various functions, heterogeneity within FAPs began to be recognized with the advent of single-cell analysis technology (<xref ref-type="bibr" rid="bib12">Contreras et al., 2021</xref>). By profiling the expression levels of 87-selected genes in isolated singlets of FAPs, dynamic transitions between heterogeneous subpopulations of FAPs, identified by different expression levels of TIE2 and VCAM1, was observed during postnatal and regenerative myogenesis (<xref ref-type="bibr" rid="bib51">Malecova et al., 2018</xref>). The report showed that while activation of TIE2<sup>high</sup> FAPs is observed in neonatal mice, activation of VCAM1<sup>+</sup> FAPs is observed in injured muscles, suggesting distinct functional involvement of FAPs in the two different contexts of myogenesis (<xref ref-type="bibr" rid="bib51">Malecova et al., 2018</xref>). Additionally, single-cell RNA-sequencing (scRNA-seq) enabled the identification of heterogeneity within FAPs based on the genome-wide transcriptome data (<xref ref-type="bibr" rid="bib43">Lieberman et al., 2021</xref>). In homeostatic adult muscle, two distinct subpopulations within FAPs have been identified, namely <italic>Dpp4</italic><sup>+</sup> and <italic>Cxcl14</italic><sup>+</sup> FAPs (<xref ref-type="bibr" rid="bib70">Scott et al., 2019</xref>; <xref ref-type="bibr" rid="bib58">Oprescu et al., 2020</xref>). Functionally, we reported that DPP4<sup>+</sup> FAPs contribute to the maturation and maintenance of the neuromuscular system via the BAP1/SMN axis (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>). In juvenile muscle, five different subpopulations within FAPs were characterized, each having different contexts of activation and differentiation potentials (<xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref>). <italic>Osr1</italic><sup>+</sup> FAPs are precursor cells that can form all other subpopulations; <italic>Clu</italic><sup>+</sup> FAPs are most potent in mineralization; <italic>Adam12</italic><sup>+</sup> and <italic>Gap43</italic><sup>+</sup> FAPs are immune-responsive; and <italic>Hsd11b1</italic><sup>+</sup> FAPs respond to nerve transection (<xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref>). The different activation cues and differentiation potentials in each subpopulation of FAPs suggest distinct roles those subsets can play in different contexts of skeletal muscle biology. Indeed, dynamic transcriptomic changes in FAP subpopulations in response to muscle injury (<xref ref-type="bibr" rid="bib70">Scott et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">De Micheli et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Oprescu et al., 2020</xref>) or denervation <xref ref-type="bibr" rid="bib56">Nicoletti et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Proietti et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">Lin et al., 2022</xref>; <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref> have been identified in studies that implemented scRNA-seq analysis. Still, the question of how FAPs may sense the distant nerve injury and whether FAPs can beneficially contribute to nerve regeneration remain largely unknown.</p><p>In response to nerve injury, various neurotrophic factors are expressed and secreted by the surrounding cells to facilitate regeneration. One of those neurotrophic factors is GDNF, previously reported to be expressed robustly by Schwann cells upon nerve injury (<xref ref-type="bibr" rid="bib23">Hammarberg et al., 1996</xref>; <xref ref-type="bibr" rid="bib29">HÃ¶ke et al., 2002</xref>; <xref ref-type="bibr" rid="bib2">Arthur-Farraj et al., 2012</xref>; <xref ref-type="bibr" rid="bib87">Xu et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Proietti et al., 2021</xref>). Canonical GDNF signaling pathway involves two well-known receptors of GDNF: RET and GFRÎ±1. Binding of GDNF to GFRÎ±1 induces complex formation with the receptor tyrosine kinase (RTK) RET, which initiates the downstream phosphorylation cascade via autophosphorylation upon dimerization (<xref ref-type="bibr" rid="bib30">Jing et al., 1996</xref>; <xref ref-type="bibr" rid="bib75">Treanor et al., 1996</xref>; <xref ref-type="bibr" rid="bib76">Trupp et al., 1996</xref>). The downstream phosphorylation cascades include the Ras-MAPK pathway, the PI3K-Akt pathway, and the Src family kinase-mediated pathway, which are known to promote neuronal survival and neurite outgrowth (<xref ref-type="bibr" rid="bib15">Encinas et al., 2001</xref>; <xref ref-type="bibr" rid="bib67">Sariola and Saarma, 2003</xref>). Indeed, exogenous delivery of GDNF was shown to promote motor neuron survival and enhance axonal growth upon nerve injury, which resulted in improved functional recovery (<xref ref-type="bibr" rid="bib10">CintrÃ³n-ColÃ³n et al., 2020</xref>). Though the role and function of GDNF on the regenerating neuron have been demonstrated, other possible cellular targets of GDNF that may facilitate the nerve regeneration process remain to be studied.</p><p>Here, using the scRNA-seq approach, we aimed to identify the response mechanism of FAPs to nerve injury, by uncovering its nerve injury-sensing mechanism and its potentially beneficial effect on nerve regeneration. To obtain a comprehensive scRNA-seq database of FAPsâ response to nerve injury, FAPs from both chronic, non-regenerating nerve injury (denervation)- and acute, regeneration-prone nerve injury (crush)-affected muscles were collected at different time points over the course of regeneration. As a result, distinct transcriptomic profiles of FAPs at different time points post the two types of nerve injuries were captured in single-cell resolution, from which the response mechanism of FAPs to nerve injury was identified and validated using mouse models. Specifically, we found that upon peripheral nerve injury, GDNF from Schwann cells can activate FAPs, which in turn express BDNF to promote remyelination during nerve regeneration. Our study suggests FAPs as an important player that actively participates in the nerve regeneration process, of which we believe should be considered in future studies aiming for an improved understanding of the peripheral nerve regeneration process.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell transcriptome profiling of nerve injury-affected FAPs</title><p>To establish a comprehensive transcriptome database of nerve injury-affected FAPs at single-cell resolution, we performed scRNA-seq using FAPs isolated from sciatic nerve crush injury (SNC)- or denervation (DEN)-affected muscles at different time points over the course of regeneration (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>). Four-time points (3, 7, 14, and 28 days post-injury, hereafter dpi) along the regeneration process were chosen for analysis to capture the transcriptomes of FAPs at both early and late stages of regeneration. Selection of such time points was based on a previous report that showed the reinnervation process of the tibialis anterior (TA) muscle after SNC, where Wallerian degeneration was evident at 7 dpi, and reinnervation was mostly completed at 28 dpi (<xref ref-type="bibr" rid="bib49">Magill et al., 2007</xref>). Including the uninjured control, scRNA-seq data from a total of nine samples (Uninjured, SNC-3dpi, SNC-7dpi, SNC-14dpi, SNC-28dpi, DEN-3dpi, DEN-7dpi, DEN-14dpi, and DEN-28dpi) were obtained via the 10x Genomics platform (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Quality control and filtering of the sequenced cells yielded a total of 44,597 cells for further analysis, where 4955.2Â±1022.8 cells were captured from each sample. Prior to downstream analysis, integration (<xref ref-type="bibr" rid="bib27">Hao et al., 2021</xref>) of our scRNA-seq data with a publicly available scRNA-seq data of mononuclear cells from denervated muscles at 0, 2, 5, and 15 dpi (<xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref>) was carried out for data validation. Expectedly, most (97.7%) of the filtered cells in our scRNA-seq data clustered with the denervation-affected FAPs in the published scRNA-seq data, confirming the validity of the data produced in our study (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell transcriptome profiling of nerve injury-affected fibro-adipogenic progenitors (FAPs).</title><p>(<bold>A</bold>) Experimental scheme depicting the procedures for sample collection and single-cell RNA-sequencing (scRNA-seq). The types of nerve injuries and time points for FAP isolation for each sample are specified. (<bold>B</bold>) Single-cell transcriptome data of nerve injury-affected FAPs displayed separately by samples on uniform manifold approximation and projection (UMAP) plots.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig1-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 1A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>Fluorescence-activated cell sorting (FACS) isolation of muscle-resident fibro-adipogenic progenitors (FAPs).</title><p>Gating strategies used for FACS isolation of FAPs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 2.</label><caption><title>Validation of single-cell RNA-sequencing (scRNA-seq) data produced in this study.</title><p>(<bold>A</bold>) Integration of scRNA-seq data obtained in this study and data from <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref> visualized on uniform manifold approximation and projection (UMAP) plots. Left: integrated data labeled with cell types; middle: cells from <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref> only; right: data from this study overlaid on top of data from <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref>. (<bold>B</bold>) Expressions of marker genes that distinguish cell types within skeletal muscle in the integrated scRNA-seq data visualized on UMAP plots.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig1-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Distinct response profiles of FAPs upon nerve crush injury versus denervation</title><p>To look into the chronological transcriptomic changes that occur in FAPs in response to SNC or DEN on a global level, we analyzed our scRNA-seq data by samples. Visualization of the scRNA-seq data on uniform manifold approximation and projection (UMAP) plots showed similar changes in the early stages of regeneration (3 and 7 dpi) compared to uninjured FAPs, regardless of the type of injury (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). However, as FAPs reached later stages of regeneration (14 and 28 dpi), SNC-affected FAPs returned to states similar to uninjured control, while DEN-affected FAPs stayed in the activated state (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The similarities and differences observed on the UMAP plots could also be found in the differentially expressed gene (DEG) analyses as well as in the hierarchical clustering analysis using those DEGs (<xref ref-type="fig" rid="fig2">Figure 2AâD</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). As a result of pairwise DEG analyses comparing all nine samples, different numbers of DEGs were identified, of which correlated with the similarities between samples observed on UMAP plots (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig2">Figure 2AâD</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1A ,B</xref>). Hierarchical clustering of the nine samples using all unique DEGs identified from the pairwise comparisons showed clustering of uninjured control with SNC-14dpi and SNC-28dpi, suggesting FAPsâ return to homeostatic state (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1C</xref>). On the other hand, DEN-14dpi and DEN-28dpi clustered with each other, but not with uninjured control, suggesting the chronic activation of FAPs in response to DEN as reported previously (<xref ref-type="bibr" rid="bib48">Madaro et al., 2018</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1C</xref>). Samples that captured the early responses of FAPs to nerve injuries (3 or 7 dpi) were clustered together by dpi rather than the type of injury, suggesting similar response profiles of FAPs to both types of nerve injuries (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1C</xref>). Indeed, the numbers of DEGs between SNC-3dpi versus DEN-3dpi and SNC-7dpi versus DEN-7dpi were among the lowest identified in the pairwise analyses (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1A</xref>). Overall, the number of DEGs between SNC- and DEN-affected FAPs increased significantly with dpi, showing the bifurcation of FAPâs response to the different types of nerve injuries in the later stages of regeneration (<xref ref-type="fig" rid="fig2">Figure 2AâD</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Distinct response profiles of fibro-adipogenic progenitors (FAPs) upon nerve crush injury versus denervation.</title><p>(<bold>AâD</bold>) Volcano plots showing different numbers of differentially expressed genes (DEGs) identified from comparing sciatic nerve crush (SNC)- versus denervation (DEN)-affected FAPs at (<bold>A</bold>) 3, (<bold>B</bold>) 7, (<bold>C</bold>) 14, (<bold>D</bold>) 28 days post injury (dpi). (<bold>EâG</bold>) Pathway terms enriched from gene set overrepresentation analyses using g:Profiler. DEGs used as input were (<bold>E</bold>) DEN-28dpi-upregulated versus SNC-28dpi, (<bold>F</bold>) SNC-28dpi-upregulated versus DEN-28dpi, and (<bold>G</bold>) DEGs upregulated commonly in SNC-3dpi, SNC-7dpi, DEN-3dpi, and DEN-7dpi versus uninjured control.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>Differentially expressed gene (DEG) analyses reveal similarities and differences between fibro-adipogenic progenitors (FAPs) affected by sciatic nerve crush (SNC) or denervation (DEN) at different time points.</title><p>(<bold>A</bold>) Number of DEGs identified from pairwise comparisons of all nine single-cell RNA-sequencing (scRNA-seq) samples visualized as a heatmap. (<bold>B</bold>) DEGs were identified by comparing nerve injury-affected FAPs versus uninjured control shown on volcano plots. (<bold>C</bold>) Hierarchical clustering of the nine scRNA-seq samples using DEGs identified in (<bold>A</bold>) displayed as a heatmap.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title>Expression patterns of <italic>Il6</italic> and <italic>Stat3</italic> in nerve injury-affected fibro-adipogenic progenitors (FAPs).</title><p>(<bold>A, C</bold>) Uniform manifold approximation and projection (UMAP) plots showing the expressions of (<bold>A</bold>) <italic>Il6</italic> and (<bold>C</bold>) <italic>Stat3</italic>. (<bold>B, D</bold>) Violin plots showing the expressions of (<bold>B</bold>) <italic>Il6</italic> and (<bold>D</bold>) <italic>Stat3</italic>, with p-values calculated buy comparing each sample to uninjured control. Wilcoxon rank sum test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 3.</label><caption><title>Gene set overrepresentation analyses using differentially expressed genes (DEGs) from pairwise comparisons of the nine single-cell RNA-sequencing (scRNA-seq) samples.</title><p>(<bold>A, B</bold>) Results from g:Profiler showing pathways enriched using DEGs upregulated in (<bold>A</bold>) denervation (DEN)-28 dpi versus sciatic nerve crush (SNC)-28 dpi and (<bold>B</bold>) vice versa. (<bold>C</bold>) Venn diagram showing the number of overlapping genes identified as DEGs by comparing each indicated sample to uninjured control. (<bold>D</bold>) Results from g:Profiler showing pathways enriched using DEGs shared in all four samples compared to uninjured control, as shown in (<bold>C</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig2-figsupp3-v1.tif"/></fig></fig-group><p>In a previous study, chronic activation of the STAT3/IL-6 pathway in FAPs in response to DEN was reported (<xref ref-type="bibr" rid="bib48">Madaro et al., 2018</xref>). Indeed, <italic>Il6</italic> was identified as one of the genes upregulated at all four-time points in response to DEN compared to uninjured control in our data (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2A, B</xref>). Although it did not pass the fold change (FC) threshold (FC â¥ 2) in the DEG analyses, expression of <italic>Stat3</italic> also showed significant chronic upregulation in all DEN-affected FAPs as well (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2C, D</xref>). In response to SNC, however, only transient upregulation of both genes was observed (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>).</p><p>To obtain biological insights on the different responses of FAPs to SNC versus DEN in the later stage of regeneration, we subjected the two lists of genes from <xref ref-type="fig" rid="fig2">Figure 2D</xref> (28 dpi, SNC_UP and DEN_UP) to gene set overrepresentation analysis (ORA) using g: Profiler (<xref ref-type="bibr" rid="bib38">Kolberg et al., 2023</xref>). From both sets of genes, pathways related to tissue regeneration/wound healing were enriched (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3A, B</xref>). In contrast, pathways related to immune cell recruitment, inflammation, and ECM regulation by collagen biosynthesis were enriched specifically in DEN-28dpi (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3A</xref>), which is consistent with the previous report that showed the direct contribution of FAPs to fibrosis in denervated muscles (<xref ref-type="bibr" rid="bib11">Contreras et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Madaro et al., 2018</xref>). Also, mild immune cell infiltration into affected muscles in response to DEN was previously described (<xref ref-type="bibr" rid="bib44">Lin et al., 2022</xref>; <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref>); our results suggest the role of FAPs in chemotactic recruitment of immune cells in denervated muscles. In addition, the pathway ânegative regulation of neuron apoptosisâ was enriched in DEN-28dpi, suggesting a prolonged attempt of FAPs to preserve neurons that must be alive for reinnervation of the denervated muscle (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3A</xref>). On the other hand, some pathways were exclusively enriched in SNC-28dpi, such as negative regulation of chemotaxis and prostaglandin metabolism (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3B</xref>). It is generally understood that after a successful tissue regeneration process, the resolution of the immune response allows for the tissue to return to homeostasis (<xref ref-type="bibr" rid="bib59">Ortega-GÃ³mez et al., 2013</xref>; <xref ref-type="bibr" rid="bib3">Aurora and Olson, 2014</xref>; <xref ref-type="bibr" rid="bib33">Julier et al., 2017</xref>); our results suggest the role of FAPs in regulating immune resolution near the end of nerve regeneration. Furthermore, the role of prostaglandin in peripheral nerve regeneration has recently been described (<xref ref-type="bibr" rid="bib18">Forese et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Bakooshli et al., 2023</xref>); our ORA results suggested that FAPs may also be involved in the regulation of prostaglandin levels during peripheral nerve regeneration.</p><p>To discover biological pathways behind the supposedly similar responses of FAPs to both SNC and DEN in the early phases of regeneration, we examined DEGs by comparing SNC-3dpi, SNC-7dpi, DEN-3dpi, and DEN-7dpi to uninjured controls. Many of the upregulated genes identified in the DEG analyses were shared amongst the four samples (<xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3C</xref>). ORA using the shared upregulated genes revealed enrichment in pathways that were also enriched in DEN-28dpi compared to SNC-28dpi, such as immune cell recruitment and ECM regulation, supporting the idea that early-activated states within FAPs persist for a prolonged period in response to DEN (<xref ref-type="fig" rid="fig2">Figure 2E and G</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3A and D</xref>). Collectively, analysis of our scRNA-seq data by samples revealed similar response profiles of FAPs to both SNC and DEN in the early stages of regeneration, which then bifurcated into chronic activation in response to DEN and return to homeostasis in response to SNC, showing correlative behaviors along with the degree of nerve regeneration and target muscle reinnervation.</p></sec><sec id="s2-3"><title>Nerve injury-responsive subsets within FAPs</title><p>Although analysis of our scRNA-seq data on the population level provided general insights on how FAPs may respond to the different types of nerve injuries, the results could not provide us with sufficient clues on how FAPs can sense nerve injuries, or how they may directly contribute to nerve regeneration. Thus, we next analyzed our scRNA-seq data on the subpopulation level, hoping to distinguish subsets within FAPs that may be more relevant to the context of sensing and responding to nerve injury. To identify distinct subsets within nerve injury-affected FAPs, we applied unsupervised clustering to the merged scRNA-seq data of all nine samples following the Seurat-R workflow (<xref ref-type="bibr" rid="bib27">Hao et al., 2021</xref>). As a result, seven clusters with unique gene expression profiles were identified from the nerve injury-affected FAPs, with marker genes specifically expressed in each cluster (<xref ref-type="fig" rid="fig3">Figure 3AâC</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Nerve injury-responsive subsets within fibro-adipogenic progenitors (FAPs).</title><p>(<bold>A</bold>) Seven clusters were identified by unsupervised clustering using all nine single-cell RNA-sequencing (scRNA-seq) samples obtained in this study displayed on the uniform manifold approximation and projection (UMAP) plot. (<bold>B</bold>) Violin plots showing expressions of unique marker genes identified in each cluster. (<bold>C</bold>) Dotplot showing the expression levels and percentages of the top 10 differentially expressed genes (DEGs) enriched in each cluster. (<bold>D</bold>) UMAP plots of clustered scRNA-seq data displayed separately by samples. (<bold>E</bold>) Barplots showing the proportions of the seven clusters that comprise each scRNA-seq sample of nerve injury-affected FAPs. For 0 dpi, data from the same uninjured control sample is displayed for both SNC and DEN.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>Marker gene expression in each fibro-adipogenic progenitor (FAP) cluster.</title><p>Uniform manifold approximation and projection (UMAP) plots showing expressions of cluster-specific marker genes identified in this study.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 2.</label><caption><title>Transcriptomic flow between fibro-adipogenic progenitor (FAP) clusters.</title><p>Results from RNA velocity analysis visualized on uniform manifold approximation and projection (UMAP) plots. Arrows indicate the predicted direction of cellular movement in the near future on the UMAP plots.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 3.</label><caption><title>Relatedness between fibro-adipogenic progenitor (FAP) clusters.</title><p>Hierarchical clustering of the seven FAP clusters displayed with a heatmap.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig3-figsupp3-v1.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 4.</label><caption><title>Expression of nerve transection-responsive fibro-adipogenic progenitor (FAP) subset-specific genes reported by <xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref> in the seven FAP clusters identified in this study.</title><p>(<bold>A</bold>) Violin plots showing the expressions of marker genes previously reported by <xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref> in the seven clusters identified in this study. (<bold>BâE</bold>) Expressions of (<bold>B</bold>) <italic>Hsd11b1</italic>, (<bold>C</bold>) <italic>Mme</italic>, (<bold>D</bold>) <italic>Ret</italic>, and (<bold>E</bold>) <italic>Gfra1</italic> in the merged single-cell RNA-sequencing (scRNA-seq) data shown on UMAP plots.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig3-figsupp4-v1.tif"/></fig></fig-group><p>Interestingly, while clusters 4â7 showed little or no significant change in their proportions in response to nerve injury, clusters 1â3 exhibited dramatic changes upon nerve injury (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). In particular, cluster 1 was mostly present in uninjured muscles or in muscles where reinnervation had occurred to at least some degree (SNC-14dpi and SNC-28dpi) (<xref ref-type="bibr" rid="bib49">Magill et al., 2007</xref>; <xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). In contrast, the presence of clusters 2 and 3 were mutually exclusive to cluster 1, such that their appearances were transient in response to SNC and chronic upon DEN (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). Based on this mutual exclusivity of the three clusters, we speculated that cluster 1 can sense and respond to nerve injuries, and that clusters 2 and 3 may have arisen from cluster 1 upon nerve injury.</p><p>To obtain clues on whether such changes between FAP clusters could have actually occurred in response to nerve injury, we first performed RNA velocity analysis using R package velocyto.R (<xref ref-type="bibr" rid="bib40">La Manno et al., 2018</xref>). RNA velocities on the UMAP plots predicted transcriptomic flow from cluster 1 to clusters 2 and 3 in the early stages of regeneration in both SNC- and DEN-affected FAPs, which was in line with our speculation (<xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). Conversely, transcriptomic flow from clusters 2 and 3 back to cluster 1 was evident in SNC-affected FAPs in the later stages of regeneration (<xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). However, RNA velocities in DEN-affected FAPs were represented as dots instead of arrows on clusters 2 and 3 in the later stages, suggesting an unchanging, chronic state of their transcriptomes, which is consistent with the chronic activation of FAPs in response to DEN (<xref ref-type="bibr" rid="bib48">Madaro et al., 2018</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). Additionally, hierarchical clustering of the seven FAP clusters using DEGs enriched in each cluster grouped clusters 1â3 together, supporting our speculation that clusters 2 and 3 originate from cluster 1 (<xref ref-type="fig" rid="fig3s3">Figure 3âfigure supplement 3</xref>). Recently, <italic>Hsd11b1</italic>-expressing FAPs were identified as the FAP subset that is specifically activated in response to nerve transection injury (<xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref>). Since we speculated that cluster 1 in our scRNA-seq data can sense and respond to nerve injury, we examined the expressions of marker genes identified in the previous report â <italic>Hsd11b1</italic>, <italic>Mme</italic>, <italic>Ret</italic>, and <italic>Gfra1</italic> (<xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref>) â in our scRNA-seq data. Indeed, all four markers were enriched in cluster 1 in our data (<xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4</xref>). Expressions of marker genes <italic>Hsd11b1</italic> and <italic>Mme</italic> were also enriched in clusters 2 and 3, further supporting the idea that those clusters may have arisen from cluster 1 (<xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4AâC</xref>). Together, these data suggest that clusters 1â3 are the dynamic interchanging subsets of FAPs that specifically respond to nerve injury, where cluster 1 senses nerve injuries in unperturbed muscles and clusters 2 and 3 arise from cluster 1 to respond to nerve injury.</p></sec><sec id="s2-4"><title>GDNF signaling pathway in the nerve injury-sensing mechanism by FAPs</title><p>Among the four marker genes expressed in cluster 1, <italic>Ret</italic> and <italic>Gfra1</italic> are well-known as GDNF receptors, where GFRÎ±1 directly binds GDNF, which in turn activates the RTK RET for downstream signal transduction (<xref ref-type="bibr" rid="bib30">Jing et al., 1996</xref>; <xref ref-type="bibr" rid="bib75">Treanor et al., 1996</xref>; <xref ref-type="bibr" rid="bib76">Trupp et al., 1996</xref>). Meanwhile, robust but specific expression of GDNF by Schwann cells in response to peripheral nerve injury has been reported (<xref ref-type="bibr" rid="bib23">Hammarberg et al., 1996</xref>; <xref ref-type="bibr" rid="bib29">HÃ¶ke et al., 2002</xref>; <xref ref-type="bibr" rid="bib2">Arthur-Farraj et al., 2012</xref>; <xref ref-type="bibr" rid="bib87">Xu et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Proietti et al., 2021</xref>). Accordingly, we presumed that FAPs, especially the <italic>Ret</italic>- and <italic>Gfra1</italic>-expressing cluster 1 cells, may sense the distant nerve injury by detecting GDNF secreted from Schwann cells. Notably, both <italic>Ret</italic> and <italic>Gfra1</italic> were among the top 10 DEGs specifically enriched in cluster 1, suggesting that they can readily respond to GDNF (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). In addition, comparing the expression levels of <italic>Ret</italic> and <italic>Gfra1</italic> in skeletal muscle-resident mononuclear cell populations isolated by fluorescence-activated cell sorting (FACS) revealed robust co-expression of both genes in FAPs, but not as much in other cell populations (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>). Thus, FAPs may be the main cell type within skeletal muscle that can respond to GDNF secreted by Schwann cells in case of a nerve injury.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Glial cell line-derived neurotrophic factor (GDNF) signaling pathway in the nerve injury-sensing mechanism by fibro-adipogenic progenitors (FAPs).</title><p>(<bold>A</bold>) Top 10 genes specifically enriched in cluster 1 FAPs. p-values were drawn from the Wilcoxon rank sum test. (<bold>B, C</bold>) RT-qPCR results show the expressions of (<bold>B</bold>) <italic>Ret</italic> and (<bold>C</bold>) <italic>Gfra1</italic> in mononuclear cells isolated from uninjured muscles by fluorescence-activated cell sorting (FACS). MuSC, muscle stem cells; Lin<sup>+</sup>, lineage-positive cells; DN, Vcam1/Sca1 double-negative cells. n=4; one-way ANOVA with Bonferroniâs post hoc test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, n.s., not significant. (<bold>D</bold>) Shared pathway terms commonly identified from gene set overrepresentation analyses using differentially expressed genes (DEGs) specifically upregulated in clusters 1, 2, or 3. See <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig4s3">3</xref> for the full overrepresentation analysis (ORA) results. (<bold>E</bold>) Venn diagram showing the results from TRRUST analyses using DEGs enriched in clusters 2 and 3. Transcription factors predicted to regulate genes upregulated in each cluster are listed. (<bold>F</bold>) Simplified diagram of the GDNF/RET-MAPK signaling pathway. Blue: GDNF ligand; orange: GDNF receptor RET expressed in cluster 1; pink: downstream cascade genes expressed in clusters 1â3; red: transcription factors commonly predicted to regulate upregulated genes in clusters 2 and 3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Pathway terms enriched in cluster 1 fibro-adipogenic progenitors (FAPs).</title><p>Results from g:Profiler showing pathways enriched in cluster 1 FAPs using genes specifically enriched in cluster 1.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 2.</label><caption><title>Pathway terms enriched in cluster 2 fibro-adipogenic progenitors (FAPs).</title><p>Results from g:Profiler showing pathways enriched in cluster 2 FAPs using genes specifically enriched in cluster 2.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 3.</label><caption><title>Pathway terms enriched in cluster 3 fibro-adipogenic progenitors(FAPs).</title><p>Results from g:Profiler showing pathways enriched in cluster 3 FAPs using genes specifically enriched in cluster 3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 4.</label><caption><title>Glial cell line-derived neurotrophic factor (GDNF) signaling pathway within the MAPK signaling pathway.</title><p>MAPK signaling pathway retrieved from KEGG (<xref ref-type="bibr" rid="bib35">Kanehisa et al., 2023</xref>), with color-coding to highlight relevant genes. Blue: GDNF ligand; orange: GDNF receptor RET expressed in cluster 1; pink: downstream cascade genes expressed in clusters 1â3; red: transcription factors (TFs) commonly predicted to regulate upregulated genes in clusters 2 and 3; green: TFs predicted to regulate genes upregulated in cluster 2; gold: TFs predicted to regulate genes upregulated in cluster 3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig4-figsupp4-v1.tif"/><permissions><copyright-statement>Â© 2023, Kanehisa Laboratories</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Kanehisa Laboratories</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Figure 4âfigure supplement 4 MAPK signaling pathway reprinted with permission from KEGG (<xref ref-type="bibr" rid="bib35">Kanehisa et al., 2023</xref>), with color-coding to highlight relevant genes. Permission was obtained from the copyright holder Kanehisa Laboratories. It is not covered by the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</ext-link> license and further reproduction of this panel would need permission from the copyright holder</license-p></license></permissions></fig></fig-group><p>To further investigate the relevance of GDNF signaling in the nerve injury-sensing mechanism by FAPs, we subjected lists of DEGs enriched in clusters 1â3 to ORA. Genes enriched in cluster 1 returned pathways âGDNF receptor signaling pathway,â âregulation of cellular response to growth factor stimulus,â and âpositive regulation of peptidyl-tyrosine phosphorylation,â where tyrosine residues on the RTK RET is known to be phosphorylated upon activation (<xref ref-type="bibr" rid="bib30">Jing et al., 1996</xref>; <xref ref-type="bibr" rid="bib75">Treanor et al., 1996</xref>; <xref ref-type="bibr" rid="bib76">Trupp et al., 1996</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref>). The two latter pathways were also found in the ORA results using DEGs enriched in clusters 2 and 3, supporting the idea that those clusters originate from cluster 1 upon nerve injury (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig4s3">3</xref>). The pathway âpositive regulation of ERK1/2 cascadeâ was enriched in cluster 2, suggesting the involvement of GDNF-RET-Ras-ERK signaling cascade within the MAPK signaling pathway in this cluster, which is one of the known downstream pathways of canonical GDNF signaling (<xref ref-type="bibr" rid="bib1">Airaksinen and Saarma, 2002</xref>; <xref ref-type="bibr" rid="bib67">Sariola and Saarma, 2003</xref>; <xref ref-type="bibr" rid="bib35">Kanehisa et al., 2023</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplements 2</xref> and <xref ref-type="fig" rid="fig4s4">4</xref>). In addition to ORA, we predicted upstream transcription factors (TFs) that could have regulated the expressions of the DEGs enriched in the two activated FAP subsets, clusters 2 and 3, using TRRUST (<xref ref-type="bibr" rid="bib24">Han et al., 2018</xref>). As a result, TFs <italic>Fos</italic>, <italic>Jun</italic> and NF-ÎºB (<italic>Nfkb1, Nfkb2</italic>) were predicted from both lists of DEGs, all of which are known to act downstream of the GDNF/RET-induced MAPK signaling pathway (<xref ref-type="bibr" rid="bib17">Fielder et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Kanehisa et al., 2023</xref>; <xref ref-type="fig" rid="fig4">Figure 4E and F</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4âfigure supplement 4</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a and b</xref>). Collectively, robust and specific co-expression of GDNF receptors in cluster 1, together with the prediction of RTK activation and involvement of GDNF signaling pathway downstream TFs in clusters 2 and 3, suggests that GDNF signaling could be the mechanism by which FAPs sense the distant nerve injury, where local Schwann cells act as the GDNF source upon nerve injury.</p></sec><sec id="s2-5"><title>The GDNF-BDNF axis as FAPâs response mechanism to nerve injury</title><p>Next, to discover how FAPs may contribute to nerve regeneration, we screened the list of genes enriched in clusters 2 and 3 that were predicted to be downstream of the GDNF signaling pathway to identify candidate effector genes. From the TRRUST analysis results, 44 genes were identified to be regulated by either <italic>Fos</italic>, <italic>Jun</italic>, or NF-ÎºB (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b and c</xref>). Since FAPs themselves do not constitute the neural components within skeletal muscle, we reasoned that secreted factors from FAPs would most likely exert a beneficial effect on the regenerating nerves. Also, considering the effector geneâs potential function in supporting nerve regeneration, we presumed that it regulates neurons or glial cells. Moreover, we anticipated that expression of the effector gene would be limited to the context of nerve injury and regeneration, since the vast majority of FAPs are in a quiescent state in unperturbed adult muscles (<xref ref-type="bibr" rid="bib70">Scott et al., 2019</xref>). Thus, we applied the following criteria to narrow down our candidate gene list: (1) genes that are known to code secreted proteins, (2) genes that are known to regulate neurons or glial cells, and (3) genes that are expressed exclusively in activated FAPs in response to nerve injury (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). Unexpectedly, after filtering out genes that did not fit the three criteria, only <italic>Bdnf</italic> remained in our candidate gene list that could act as the effector secreted by FAPs upon nerve injury to support nerve regeneration (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Expression patterns of <italic>Bdnf</italic> in FAPs upon nerve injury showed transient upregulation in SNC-affected FAPs, whereas chronic expression of <italic>Bdnf</italic> was observed in DEN-affected FAPs, showing correlation with its potential requirement during nerve regeneration (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The expression of <italic>Bdnf</italic> was mostly limited to cluster 2 (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>), where pathway analysis and TF prediction suggested the involvement of GDNF-RET-Ras-ERK-Fos signaling cascade in this subset of FAPs (<xref ref-type="fig" rid="fig4">Figure 4DâF</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig4s4">4</xref>). Accordingly, we hypothesized that FAPs secrete BDNF in response to GDNF from Schwann cells upon nerve injury, to actively take part in the regeneration process.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The GDNF-BDNF axis as fibro-adipogenic progenitors (FAPs) response mechanism to nerve injury.</title><p>(<bold>A</bold>) Identification of candidate genes expressed in FAPs in response to glial cell line-derived neurotrophic factor (GDNF) that may contribute to nerve regeneration. Number of genes that fit into each criterion is indicated. (<bold>B</bold>) Expression of <italic>Bdnf</italic> in each scRNA-seq sample shown on uniform manifold approximation and projection (UMAP) plots. (<bold>C</bold>) Violin plot displaying the expression levels of <italic>Bdnf</italic> in the seven FAP clusters. (<bold>D</bold>) Scheme for sampling Schwann cells and FAPs at different time points post sciatic nerve crush (SNC) for gene expression analyses. (<bold>E</bold>) RT-qPCR results showing expression levels of <italic>Gdnf</italic> in Schwann cells (orange dot and line, left y-axis) and <italic>Bdnf</italic> in FAPs (blue dot and line, right y-axis) at different time points post-SNC. n=4, except for 0 and 2 dpi, where n=3. One-way ANOVA with Bonferroniâs post hoc test. *p&lt;0.05, ***p&lt;0.001, n.s., not significant. (<bold>F</bold>) Western blot results showing BDNF protein expression in PDGFRÎ±<sup>+</sup> FAPs isolated from SNC-affected or uninjured contralateral muscles at 7 dpi. n=3. Mature form of BDNF is indicated with a red asterisk. Quantified values normalized to GAPDH is indicated below each protein. See <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref> for the experimental scheme. (<bold>G</bold>) Scheme for intramuscular injection of either PBS or recombinant mouse GDNF protein, with the time point for FAP isolation post-injection indicated. (<bold>H</bold>) RT-qPCR results show the expression level of <italic>Bdnf</italic> in FAPs 48 hr post intramuscular injection of either PBS (n=4) or GDNF (n=5). Unpaired t-test with Welchâs correction. **p&lt;0.01.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5âsource data 1.</label><caption><title>The zip file contains raw western blot images, a marker image, and a marker-merged, labeled image obtained for <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-97662-fig5-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig5-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 5G was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>Scheme for western blot analysis.</title><p>Experimental scheme depicting sample collection for fibro-adipogenic progenitor (FAP) isolation and the timeline for sciatic nerve crush (SNC) and FAP isolation for the western blot analysis done in <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig5-figsupp1-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 5âfigure supplement 1 was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 2.</label><caption><title>Decreased intramuscular glial cell line-derived neurotrophic factor (GDNF) activity can weaken <italic>Bdnf</italic> induction in fibro-adipogenic progenitors (FAPs) upon nerve injury.</title><p>(<bold>A</bold>) Experimental scheme depicting intramuscular injection of either anti-GDNF antibodies or IgG control after sciatic nerve crush (SNC), along with the experimental timeline. (<bold>B</bold>) RT-qPCR results show the expression levels of <italic>Bdnf</italic> in nerve injury-exposed FAPs affected by intramuscular injection of either IgG control or anti-GDNF antibodies. n=4. Unpaired t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig5-figsupp2-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 5âfigure supplement 2A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig></fig-group><p>To validate our hypothesis in vivo, we first examined the expression profiles of <italic>Gdnf</italic> in Schwann cells and <italic>Bdnf</italic> in FAPs at early time points in response to SNC, using <italic>Plp1<sup>CreER</sup>; Rosa26<sup>LSL-tdTomato</sup></italic> mice to specifically label and hence isolate Schwann cells (<xref ref-type="bibr" rid="bib14">Doerflinger et al., 2003</xref>; <xref ref-type="fig" rid="fig5">Figure 5D</xref>). Expectedly, we could observe sequential upregulation of <italic>Gdnf</italic> and <italic>Bdnf</italic> from Schwann cells and FAPs, respectively, where <italic>Gdnf</italic> levels peaked at 1 dpi in Schwann cells, followed by a gradual increase of <italic>Bdnf</italic> expression in FAPs, which peaked at 3 dpi (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Following mRNA expression validation in vivo, we performed western blot analysis using FAPs isolated from either SNC-affected muscles at 7 dpi or from the contralateral, uninjured muscles to validate the expression of BDNF protein upon nerve injury (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). FAPs from both uninjured muscles and SNC-affected muscles showed robust expression of PDGFRÎ±, a well-known marker for FAPs (<xref ref-type="bibr" rid="bib31">Joe et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Uezumi et al., 2010</xref>), indicating successful isolation and protein extraction from the sorted FAPs (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). However, unlike PDGFRÎ±, the mature form of BDNF protein could only be detected in SNC-affected FAPs, but not in uninjured FAPs, showing correlative results with the mRNA expression pattern of <italic>Bdnf</italic> in FAPs upon nerve injury (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). These results demonstrate the expression of BDNF in nerve injury-affected FAPs, but not in uninjured FAPs, on both mRNA and protein levels.</p><p>Next, to validate the sufficiency of GDNF signaling in inducing <italic>Bdnf</italic> expression in FAPs in vivo, we injected recombinant mouse GDNF protein into the TA and the two gastrocnemius (GA) muscles (lateral and medial GA), from which FAPs were FACS-isolated 48 hr post-injection to investigate the expression of <italic>Bdnf</italic> (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Compared to PBS control, intramuscular injection of GDNF sufficiently induced <italic>Bdnf</italic> expression in FAPs, even in the absence of a nerve injury (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Conversely, to show the necessity of GDNF signaling in the upregulation of <italic>Bdnf</italic> in FAPs upon nerve injury, we injected either IgG control or anti-GDNF antibodies into the TA and GA muscles 24 hr after SNC, and FACS-isolated FAPs 48 hr post-injection for analysis. Though the results were not statistically significant, injection of GDNF-blocking antibodies showed a tendency to reduce <italic>Bdnf</italic> expression compared to IgG-injected controls, which is in support of our hypothesis (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>). Together, we suggest that FAPs can respond to nerve injury via the GDNF-BDNF axis, since recombinant GDNF protein could sufficiently induce <italic>Bdnf</italic> expression in FAPs without nerve injury, and reduced GDNF activity could weaken <italic>Bdnf</italic> expression in the nerve injury-affected FAPs.</p></sec><sec id="s2-6"><title>Remyelination by FAP-derived BDNF during peripheral nerve regeneration</title><p>Although BDNF is known to function in processes such as axon elongation (<xref ref-type="bibr" rid="bib60">Oudega and Hagg, 1999</xref>; <xref ref-type="bibr" rid="bib16">English et al., 2013</xref>), survival of neurons (<xref ref-type="bibr" rid="bib19">Ghosh et al., 1994</xref>; <xref ref-type="bibr" rid="bib5">Baydyuk and Xu, 2014</xref>), and myelination by Schwann cells (<xref ref-type="bibr" rid="bib88">Zhang et al., 2000</xref>; <xref ref-type="bibr" rid="bib8">Chan et al., 2001</xref>; <xref ref-type="bibr" rid="bib86">Xiao et al., 2009</xref>), the role of BDNF secreted by FAPs in nerve regeneration is unknown. To find out how FAP-derived BDNF can contribute to nerve regeneration, we produced conditional knockout (cKO) mice where <italic>Bdnf</italic> is specifically inactivated in mesenchymal progenitors including FAPs, by crossing <italic>Prrx1<sup>Cre</sup></italic> mice (<xref ref-type="bibr" rid="bib46">Logan et al., 2002</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref>; <xref ref-type="bibr" rid="bib25">Hann et al., 2024</xref>) with <italic>Bdnf</italic>-floxed (<italic>Bdnf<sup>fl</sup></italic>) mice (<italic>Prrx1<sup>Cre</sup>; Bdnf<sup>fl/fl</sup></italic>, hereafter cKO) (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1A</xref>). Inactivation of <italic>Bdnf</italic> in FAPs in the cKO mice was confirmed on both genomic DNA and mRNA levels (<xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1B, C</xref>). Though Cre expression in <italic>Prrx1</italic>-expressing cells occurs from embryonic day 9.5 (<xref ref-type="bibr" rid="bib46">Logan et al., 2002</xref>), no visible phenotypes were observed in the postnatal, juvenile, and adult cKO mice compared to littermate controls (hereafter, Ctrl). However, upon SNC in the right hindlimb, cKO mice displayed a delay in nerve regeneration compared to Ctrl, measured by compound muscle action potential (CMAP) amplitude and latency via electromyography (EMG) on the GA muscle (<xref ref-type="fig" rid="fig6">Figure 6AâD</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1D, E</xref>). At 4 weeks post-injury (wpi), nerve regeneration in both Ctrl and cKO mice showed insufficient recovery in the right, injured GA compared to the left, uninjured GA, where lower amplitude and prolonged latency in CMAP was observed (<xref ref-type="fig" rid="fig6">Figure 6BâD</xref>). However, at 6 wpi, while CMAP amplitude and latency in the left and right GAs became comparable in Ctrl mice, recovery of such values were stalled at levels comparable to 4 wpi in the cKO mice (<xref ref-type="fig" rid="fig6">Figure 6BâD</xref>). By 12 wpi, electrophysiological functions of the injured nerves became statistically comparable to that of its contralateral counterpart in the cKO mice, indicating a delayed regeneration in the cKO mice (<xref ref-type="fig" rid="fig6">Figure 6BâD</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Remyelination by fibro-adipogenic progenitor (FAP)-derived BDNF during peripheral nerve regeneration.</title><p>(<bold>A</bold>) Experimental scheme displaying mice used and the time points selected for electromyography (EMG) measurements and sciatic nerve dissection. wpi, weeks post-injury. (<bold>B</bold>) Representative EMG measurement results of both injured and uninjured gastrocnemius (GA) muscles from Ctrl or conditional knockout (cKO) mice at the indicated time points post-sciatic nerve crush (SNC). (<bold>C, D</bold>) Quantified results of EMG measurement showing (<bold>C</bold>) compound muscle action potential (CMAP) amplitude and (<bold>D</bold>) CMAP latency. n=5. One-way ANOVA with Bonferroniâs post hoc test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, n.s., not significant. (<bold>E</bold>) Representative images showing toluidine blue-stained, semi-thin cross-sections of sciatic nerves dissected from Ctrl or cKO mice at 6 wpi. Scale bars, 10 Î¼m. (<bold>FâG</bold>) Quantification of (<bold>F</bold>) calculated G-ratio values and (<bold>G</bold>) axon diameters from analyzing toluidine blue-stained sciatic nerve sections dissected from Ctrl or cKO mice at 6 wpi. 50 axons were randomly selected from each sciatic nerve for quantification. n=5. Mann-Whitney U test. ***p&lt;0.001, n.s., not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig6-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 6A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6âfigure supplement 1.</label><caption><title>Validation of conditional knockout (cKO) mice used in this study and methods used for analysis.</title><p>(<bold>A</bold>) Genomic loci and structure of <italic>Prrx1<sup>Cre</sup></italic> and <italic>Bdnf<sup>fl</sup></italic> alleles labeled with primers used for genotyping and genomic DNA recombination validation. (<bold>B</bold>) Results from genotyping (left and middle) and genomic DNA recombination PCR (right). Genomic DNA recombination of the LoxP flanking sites in the cKO mice were confirmed using primers P4 and P6 shown in (<bold>A</bold>). (<bold>C</bold>) RT-qPCR results of <italic>Bdnf</italic> expression using FAPs isolated from either Ctrl or cKO mice at 3 or 7 days post-sciatic nerve crush (SNC). n=2; Two-way ANOVA. **p&lt;0.01. (<bold>D</bold>) Scheme for CMAP measurement showing the positions of electrodes used. (<bold>E</bold>) Diagram of a typical CMAP graph along with amplitude and latency used for analysis. (<bold>F</bold>) Diagram depicting calculation of G-ratio. (<bold>G</bold>) Examples of images from G-ratio quantification using ImageJ plugin GRatio for ImageJ. The outer (cyan) and inner (magenta) borders of myelin were manually drawn on randomly selected axons for quantification of axon diameter and G-ratio. (<bold>H</bold>) Scatter plots with linear regressions displaying G-ratios (y-axis) in relation to axon diameters (x-axis). Solid lines are linear regressions and dotted lines represent errors with a 95% confidence level. ANCOVA, ***p&lt;0.001.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6âfigure supplement 1âsource data 1.</label><caption><title>The zip file contains raw DNA electrophoresis gel images and labeled images obtained for <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-97662-fig6-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig6-figsupp1-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 6âfigure supplement 1DâF was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig></fig-group><p>Generally, a decrease in CMAP amplitude and prolonged CMAP latency can be explained by two main causes: axonal loss and defective myelination (<xref ref-type="bibr" rid="bib52">Mallik and Weir, 2005</xref>; <xref ref-type="bibr" rid="bib9">Chung et al., 2014</xref>). Since complete regeneration of the injured nerves on the electrophysiological level could be achieved after a sufficient period of time in the cKO mice (<xref ref-type="fig" rid="fig6">Figure 6BâD</xref>), we presumed that axonal loss would not have occurred, since it would result in permanent defects by loss of motor units. Instead, we thought that defective myelination could have occurred in the cKO mice, considering the fact that BDNF is already known to promote remyelination during peripheral nerve regeneration (<xref ref-type="bibr" rid="bib88">Zhang et al., 2000</xref>; <xref ref-type="bibr" rid="bib8">Chan et al., 2001</xref>; <xref ref-type="bibr" rid="bib90">Zheng et al., 2016</xref>), and that defective myelination alone can affect both CMAP amplitude and latency (<xref ref-type="bibr" rid="bib52">Mallik and Weir, 2005</xref>). Thus, we investigated the effect of conditional <italic>Bdnf</italic> inactivation in FAPs on regenerative myelination by examining the sciatic nerves from Ctrl versus cKO mice at 6 wpi, when the delayed functional recovery of the injured nerves in the cKO mice was prominent (<xref ref-type="fig" rid="fig6">Figure 6AâD</xref>). Toluidine blue staining of the semi-thin sections of injured sciatic nerves revealed significantly reduced myelin thickness in the cKO mice compared to Ctrl mice (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Indeed, higher G-ratio values were calculated from cKO mice compared to Ctrl, confirming the reduced myelination in the regenerating nerves in cKO mice (<xref ref-type="fig" rid="fig6">Figure 6F</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1FâH</xref>). This decrease in myelin thickness was independent from axon diameter, which were comparable in both Ctrl and cKO mice, implying that no axonal loss or defect had occurred in the cKO mice compared to controls (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Taken together, our results revealed the direct involvement of FAP-derived BDNF in the remyelination process during peripheral nerve regeneration, such that inadequate levels of <italic>Bdnf</italic> expression in FAPs caused delayed remyelination and hence delayed nerve regeneration in the cKO mice.</p></sec><sec id="s2-7"><title>Implication of FAP-derived BDNF in the age-related delay in nerve regeneration</title><p>Finally, to seek the clinical relevance of <italic>Bdnf</italic> expression in FAPs during nerve regeneration, we compared the expression levels of <italic>Bdnf</italic> in adult (5â6 months) versus aged (24 months) mice in FAPs post-SNC. At 7 dpi, <italic>Bdnf</italic> expression was significantly reduced in the aged mice compared to adult mice (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>). Such a difference could be one of the factors that lead to the delayed or failed regeneration of injured nerves in the elderly compared to healthy, young adults, suggesting the clinical role of FAPs in a timely, successful peripheral nerve regeneration process.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Implication of fibro-adipogenic progenitor (FAP)-derived BDNF in the age-related delay in nerve regeneration.</title><p>(<bold>A</bold>) Experimental scheme indicating the ages of mice used and the time point for FAP isolation to compare the expression level of <italic>Bdnf</italic> post-sciatic nerve crush (SNC). (<bold>B</bold>) RT-qPCR results show the expression level of <italic>Bdnf</italic> in FAPs isolated from either adult (5â6 months) or aged (24 months) mice at 7 dpi. n=5. Unpaired t-test. **p&lt;0.01. (<bold>C</bold>) Graphical summary of this study.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig7-v1.tif"/><permissions><copyright-statement>Â© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 7A and C was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Traumatic injury to the peripheral nerve has severe consequences, including lifelong paralysis of the injured limb that can compromise the quality of life significantly (<xref ref-type="bibr" rid="bib22">Grinsell and Keating, 2014</xref>). Thus, understanding the regeneration process of the peripheral nerves is fundamental for treating the potentially devastating injury. Previously, several cellular components in and outside the injured nerve were discovered to actively participate in the regeneration process, including the injured neurons (<xref ref-type="bibr" rid="bib26">Hanz et al., 2003</xref>), glial cells (<xref ref-type="bibr" rid="bib2">Arthur-Farraj et al., 2012</xref>), immune cells (<xref ref-type="bibr" rid="bib54">Mueller et al., 2001</xref>; <xref ref-type="bibr" rid="bib34">Kalinski et al., 2020</xref>), and nerve-resident mesenchymal cells (<xref ref-type="bibr" rid="bib62">Parrinello et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Toma et al., 2020</xref>), via diverse mechanisms so that the nerve can regain its function (<xref ref-type="bibr" rid="bib68">Scheib and HÃ¶ke, 2013</xref>). In this study, we investigated the response mechanism of muscle-resident FAPs to both acute and chronic peripheral nerve injury via scRNA-seq, and revealed that this population of cells can also actively take part in the nerve regeneration process. Here, we discovered that muscle-resident FAPs can recognize the distant nerve injury by sensing GDNF secreted by Schwann cells. Though GDNF secretion by Schwann cells in response to nerve injury had previously been recognized (<xref ref-type="bibr" rid="bib23">Hammarberg et al., 1996</xref>; <xref ref-type="bibr" rid="bib29">HÃ¶ke et al., 2002</xref>; <xref ref-type="bibr" rid="bib2">Arthur-Farraj et al., 2012</xref>; <xref ref-type="bibr" rid="bib87">Xu et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Proietti et al., 2021</xref>), we identified FAPs as a major target cell population of GDNF within skeletal muscle, based on the enriched expression of GDNF receptors. In-depth, exploiting the technical advantage of scRNA-seq, we suggested that a subset of FAPs, named cluster 1 in this study, can sense the local GDNF by expressing GDNF receptors <italic>Ret</italic> and <italic>Gfra1</italic>, and that upon GDNF sensing, cluster 1 FAPs turn into clusters 2 and 3 to contribute to the nerve regeneration process. Specifically, we discovered that FAPs, especially the <italic>F2rl1</italic>-expressing cluster 2, express <italic>Bdnf</italic> in response to nerve injury and/or GDNF, which in turn was shown to promote the remyelination process by Schwann cells during nerve regeneration, using our cKO mouse model (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Since epineurial and perineurial, but not endoneurial mesenchymal cells share their origins with the muscle-resident FAPs and, therefore, are <italic>Prrx1</italic>-positive (<xref ref-type="bibr" rid="bib32">Joseph et al., 2004</xref>; <xref ref-type="bibr" rid="bib7">Carr et al., 2019</xref>), the possibility that the delayed remyelination observed in our cKO mice could be due to the combined effect of <italic>Bdnf</italic> depletion in both muscle- and nerve-resident mesenchymal cells cannot be eliminated. To resolve such an issue, further investigations using muscle-resident FAP-specific Cre mouse lines are required, but such a line is currently unavailable as no such specific marker has been found. Nevertheless, our findings show that muscle-resident FAP-derived BDNF is indeed important for nerve regeneration, since intramuscular injection of recombinant BDNF can sufficiently accelerate the nerve regeneration process (<xref ref-type="bibr" rid="bib90">Zheng et al., 2016</xref>). Conversely, intramuscular injection of BDNF-neutralizing antibodies can sufficiently delay nerve regeneration (<xref ref-type="bibr" rid="bib90">Zheng et al., 2016</xref>). Thus, endogenous supply of intramuscular BDNF by the muscle-resident FAPs in our Ctrl mice would likely have supported remyelination by Schwann cells, while the lack of such BDNF supply by FAPs in our cKO mice would have resulted in delayed remyelination. Also, we found that while muscle-resident FAPs robustly express both GDNF receptor genes, neither epineurial nor perineurial mesenchymal cells express significant levels of <italic>Ret</italic> and <italic>Gfra1</italic> (<xref ref-type="bibr" rid="bib7">Carr et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Toma et al., 2020</xref>; <xref ref-type="bibr" rid="bib89">Zhao et al., 2022</xref>; <xref ref-type="fig" rid="fig8">Figure 8</xref>), implying that the GDNF-BDNF axis found in this study could be valid uniquely in muscle-resident FAPs. Collectively, we suggest that muscle-resident mesenchymal progenitors can directly contribute to nerve regeneration via the GDNF-BDNF axis (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), of which was previously unidentified; we suggest that in future studies regarding peripheral nerve regeneration, active participation of this intramuscular mesenchymal population should be taken into consideration. In that process, our scRNA-seq data may provide valuable insights, which may lead to additional discoveries on FAPâs contributions to nerve regeneration by other mechanisms, and/or provide clues on the cell-to-cell communications of FAPs with other cell types that may lead to facilitation of the regeneration process.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Expression of glial cell line-derived neurotrophic factor (GDNF) receptor genes <italic>Ret</italic> and <italic>Gfra1</italic> in nerve-resident cells.</title><p>(<bold>AâC</bold>) Single-cell RNA-sequencing (scRNA-seq) data from <xref ref-type="bibr" rid="bib7">Carr et al., 2019</xref> and <xref ref-type="bibr" rid="bib74">Toma et al., 2020</xref> (accession numbers: GSM3408137, GSM3408139, GSM4423509, and GSM4423506) were merged into a single Seurat object and visualized on uniform manifold approximation and projection (UM)AP plots. Cell types identified using markers listed by <xref ref-type="bibr" rid="bib74">Toma et al., 2020</xref> are shown in (<bold>A</bold>), and expression levels of (<bold>B</bold>) <italic>Ret</italic> and (<bold>C</bold>) <italic>Gfra1</italic> are displayed. epi.MES: epineurial mesenchymal cells; peri.MES: perineurial mesenchymal cells; endo.MES: endoneurial mesenchymal cells; diff.MES: differentiating mesenchymal cells; prol.MES: proliferating mesenchymal cells; NM.SC: non-myelinating Schwann cells; MY.SC: myelinating Schwann cells; Mac/Mo: macrophage/monocyte. (<bold>DâF</bold>) scRNA-seq data from <xref ref-type="bibr" rid="bib89">Zhao et al., 2022</xref> (accession number: GSE198582) were merged into a single Seurat object and visualized on UMAP plots. Cell types annotated by <xref ref-type="bibr" rid="bib89">Zhao et al., 2022</xref> are shown in (<bold>D</bold>), and expression levels of (<bold>E</bold>) <italic>Ret</italic> and (<bold>F</bold>) <italic>Gfra1</italic> are displayed. cDC: conventional dendritic cells; DCx: dendritic cells destined for homing; dMES: differentiating mesenchymal cells; EC: endothelial cells; eMES: endoneurial mesenchymal cells; Fb: fibroblasts; GC: granulocytes; Mac: macrophages; Mast: mast cells; Mo: monocytes; MoDC: monocyte-derived dendritic cells; NK: natural killer cells; pDC: plasmocytoid dendritic cells; pMES: perineurial mesenchymal cells; prol.MES: proliferating mesenchymal cells; SC: Schwann cells; TC: T cells; vSMC_PC: vascular smooth muscle cells/pericytes; NA: not applicable.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig8-v1.tif"/></fig><p>Here, we have primarily investigated the roles of <italic>Ret</italic>-expressing and <italic>F2rl1</italic>-expressing FAPs in sensing and responding to nerve injury, respectively. However, possibilities that other subpopulations can exert distinct beneficial effects on nerve regeneration remain largely unexplored. For example, although identified as a nerve injury-relevant subpopulation in this study, specific contributions of the <italic>Alkal2</italic>-expressing cluster 3 FAPs to nerve regeneration are yet to be discovered. Identification of effector genes such as <italic>Bdnf</italic> from this subpopulation may lead to the discovery of an additional mechanism by which FAPs can contribute to nerve regeneration. Although other subpopulations (clusters 4â7) did not exhibit dramatic fluctuations in population percentage, some of the genes expressed specifically in those subpopulations showed patterns that followed the regeneration process (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Such gene expression patterns suggest subpopulation-specific functions even in the less dynamic subpopulations within FAPs in peripheral nerve regeneration, and require further investigations to reveal their possible contributions.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Expression of nerve injury-induced, cluster-specific genes in fibro-adipogenic progenitors (FAPs).</title><p>(<bold>A, B</bold>) Expressions of (<bold>A</bold>) <italic>Rspo1</italic> and (<bold>B</bold>) <italic>Csmd1</italic> are shown on uniform manifold approximation and projection (UMAP) plots, separated by samples. Single-cell RNA-sequencing (scRNA-seq) data obtained in this study were used.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig9-v1.tif"/></fig><p>The role of BDNF in peripheral nerve regeneration has been identified previously, where it was found to promote both intrinsic axonal regeneration in neurons as well as remyelination by Schwann cells (<xref ref-type="bibr" rid="bib88">Zhang et al., 2000</xref>; <xref ref-type="bibr" rid="bib8">Chan et al., 2001</xref>; <xref ref-type="bibr" rid="bib90">Zheng et al., 2016</xref>). In such circumstances, various cellular sources of BDNF have been identified. Bone marrow transplantation of wild-type cells into <italic>Bdnf</italic> heterozygotic knockout mice revealed the involvement of bone marrow-derived cells in expressing <italic>Bdnf</italic> that can promote nerve regeneration in the sciatic nerve (<xref ref-type="bibr" rid="bib72">Takemura et al., 2012</xref>). Schwann cells themselves are cellular sources of BDNF during nerve regeneration (<xref ref-type="bibr" rid="bib84">Wilhelm et al., 2012</xref>). In this study, we showed that BDNF from FAPs can also promote myelination of the regenerating axons post-injury, suggesting FAPs as an additional cellular source of BDNF in peripheral nerve regeneration. The existence of cellular sources of BDNF other than FAPs such as Schwann cells would provide an explanation for the delayed, but not failed, remyelination in our <italic>Bdnf</italic> cKO mice, where complete regeneration had occurred after a sufficient amount of time, despite the lack of <italic>Bdnf</italic> expression in FAPs. Still, ablation of <italic>Bdnf</italic> in FAPs displayed significant delays in the remyelination process during nerve regeneration, suggesting their requirement in the timely regeneration process of injured nerves. Meanwhile, scRNA-seq data of all mononuclear cells from denervated muscles (<xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref>) suggested expression of <italic>Bdnf</italic> in tenocytes and pericytes in addition to Schwann cells and FAPs (<xref ref-type="fig" rid="fig10">Figure 10A and B</xref>). Although this may imply the involvement of those cellular components in providing BDNF for nerve regeneration, expression of <italic>Bdnf</italic> in such cells were not altered as significantly in response to nerve injury as in FAPs or Schwann cells (<xref ref-type="fig" rid="fig10">Figure 10C</xref>). Moreover, while <italic>Ret</italic>-expressing FAPs and Schwann cells are known to be in proximity to the NMJ or relevant nerve regeneration sites (<xref ref-type="bibr" rid="bib41">Leinroth et al., 2022</xref>), such locational enrichment of tenocytes and pericytes have not been reported so far. Thus, it is likely that FAPs, together with Schwann cells, are the main sources of BDNF within skeletal muscle that can act in the remyelination process during peripheral nerve regeneration.</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Expression of <italic>Bdnf</italic> in muscle-resident mononuclear cells affected by denervation.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) plot showing data from <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref> labeled by cell types identified. (<bold>B</bold>) Expression pattern of <italic>Bdnf</italic> in data from <xref ref-type="bibr" rid="bib57">Nicoletti et al., 2023</xref> shown on UMAP plots, separately by days post denervation. (<bold>C</bold>) Expression of <italic>Bdnf</italic> in each cell type on different days post-denervation displayed in violin plots. p-values were calculated by comparing each injury-affected cellsâ expression levels versus its uninjured state (0 dpi). Only significant p-values are shown. Wilcoxon rank sum test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-fig10-v1.tif"/></fig><p>Aging is one of the well-known factors that can slow down the nerve regeneration process (<xref ref-type="bibr" rid="bib82">VerdÃº et al., 2000</xref>; <xref ref-type="bibr" rid="bib50">Maita et al., 2023</xref>). Since multiple cell types are known to participate in this process (<xref ref-type="bibr" rid="bib68">Scheib and HÃ¶ke, 2013</xref>), the determination of the cell types that can cause age-related delays in nerve regeneration is important for the development of therapeutic approaches targeting the relevant cell types. Of note, previous research emphasized the importance of niche factors, rather than the intrinsic regenerative capacity of the injured neurons, in the age-related decline in nerve regeneration (<xref ref-type="bibr" rid="bib61">Painter et al., 2014</xref>). Specifically, the inability of Schwann cells to adopt repair cell phenotypes has been pointed out as one of the age-related changes (<xref ref-type="bibr" rid="bib61">Painter et al., 2014</xref>; <xref ref-type="bibr" rid="bib83">Wagstaff et al., 2021</xref>). In addition, age-related changes in immune cells, especially macrophages, were suggested as causal factors that delay nerve regeneration (<xref ref-type="bibr" rid="bib6">BÃ¼ttner et al., 2018</xref>). In particular, chronic inflammatory phenotypes were shown to interfere with the remyelination process by Schwann cells (<xref ref-type="bibr" rid="bib6">BÃ¼ttner et al., 2018</xref>), and failed macrophage infiltration in the early stages of regeneration resulted in defective Wallerian degeneration and myelin debris clearing (<xref ref-type="bibr" rid="bib69">Scheib and HÃ¶ke, 2016</xref>). In addition to the involvement of Schwann cells and immune cells, we have identified muscle-resident FAPs as an additional cellular component that can contribute to nerve regeneration, by promoting remyelination via BDNF secretion. Surprisingly, expression of <italic>Bdnf</italic> by FAPs was significantly reduced in aged mice compared to adult mice, suggesting the clinical relevance of FAPâs involvement in the age-related delay in peripheral nerve regeneration. We believe that further studies on age-related changes in FAPs may provide valuable clues to understanding clinical observations from aged individuals, which can lead to the development of additional therapeutic strategies that include FAPs as target cells in treating both young and aged nerve injury patients.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-mouse CD31 (Rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 102510, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312917">AB_312917</ext-link></td><td align="left" valign="bottom">FACS, 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-mouse CD45 (Rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 103112, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312977">AB_312977</ext-link></td><td align="left" valign="bottom">FACS, 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-mouse TER-119 (Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 116208, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313709">AB_313709</ext-link></td><td align="left" valign="bottom">FACS, 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Biotin anti-mouse CD106 (Vcam1) (Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 105704, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313205">AB_313205</ext-link></td><td align="left" valign="bottom">FACS, 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-mouse Ly-6A/E (Sca1) (Rat monoclonal)</td><td align="left" valign="bottom">BD Pharmingen</td><td align="left" valign="bottom">Cat# 553335, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394791">AB_394791</ext-link></td><td align="left" valign="bottom">FACS, 1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GAPDH (rabbit polyclonal)</td><td align="left" valign="bottom">Bethyl Laboratories</td><td align="left" valign="bottom">Cat# A300-641A, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_513619">AB_513619</ext-link></td><td align="left" valign="bottom">WB, 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-PDGFRÎ± (rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-338, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_631064">AB_631064</ext-link></td><td align="left" valign="bottom">WB, 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-BDNF (rabbit polyclonal)</td><td align="left" valign="bottom">Alomone Labs</td><td align="left" valign="bottom">Cat# ANT-010, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2039756">AB_2039756</ext-link></td><td align="left" valign="bottom">WB, 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GDNF (rabbit polyclonal)</td><td align="left" valign="bottom">Alomone Labs</td><td align="left" valign="bottom">Cat# ANT-014, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2039876">AB_2039876</ext-link></td><td align="left" valign="bottom">10 Î¼g per injection</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Normal rabbit IgG (polyclonal)</td><td align="left" valign="bottom">Sino Biological</td><td align="left" valign="bottom">Cat# CR1, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_3073921">AB_3073921</ext-link></td><td align="left" valign="bottom">10 Î¼g per injection</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">horseradish peroxidase-conjugated anti-rabbit IgG (goat polyclonal)</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# W4011, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_430833">AB_430833</ext-link></td><td align="char" char="." valign="bottom">1:10,000</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tamoxifen</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# T5648</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">2,2,2-Tribromoethanol (Avertin)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# T48402</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">7-aminoactinomycin D (7-AAD)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# SML1633</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PE/Cyanine7 Streptavidin</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat# 405206</td><td align="char" char="." valign="bottom">1:100</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TRIzol Reagent</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# 15596â018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# P6148</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium cacodylate buffer</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">Cat# 11652</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Osmium tetroxide</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">Cat# 19190</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Uranyl acetate solution</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">Cat# 22400</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Propylene oxide</td><td align="left" valign="bottom">Tokyo Chemical Industry</td><td align="left" valign="bottom">Cat# E0016</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Spurrâs resin</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">Cat# 14300</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Toluidine blue</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# 89640</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium borate</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# B9876</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">wild type B6: C57BL/6 J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Prrx1<sup>Cre</sup></italic>: B6.Cg-Tg(Prrx1-cre)1Cjt/J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005584">IMSR_JAX:005584</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Bdnf<sup>fl</sup></italic>: Bdnf<sup>tm3Jae</sup>/J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004339">IMSR_JAX:004339</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Plp1<sup>CreER</sup></italic>: B6.Cg-Tg(Plp1-cre/ERT)3Pop/J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005975">IMSR_JAX:005975</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Rosa26<sup>LSL-tdTomato</sup></italic>: B6.Cg-Gt(ROSA)26Sor<sup>tm14(CAG-tdTomato)Hze</sup>/J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007914">IMSR_JAX:007914</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant mouse GDNF</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# SRP3200</td><td align="left" valign="bottom">10 Î¼g/ml, 10 Î¼l per injection</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Chromium Next GEM Single Cell 3Ê¹ Kit v3.1</td><td align="left" valign="bottom">10 X Genomics</td><td align="left" valign="bottom">Cat# PN-1000268</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ReverTra Ace qPCR RT Master Mix</td><td align="left" valign="bottom">Toyobo</td><td align="left" valign="bottom">Cat# FSQ-201</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ORA SEE qPCR Green ROX L Mix</td><td align="left" valign="bottom">HighQu</td><td align="left" valign="bottom">Cat# QPD0550</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CellRanger v3.1.0</td><td align="left" valign="bottom">10 X Genomics</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_023221">SCR_023221</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Velocyto v0.17</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">La Manno et al., 2018</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018167">SCR_018167</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package Seurat v4.3.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Hao et al., 2021</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016341">SCR_016341</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package SeuratWrappers v0.3.1</td><td align="left" valign="bottom">Satija Lab</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022555">SCR_022555</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package pheatmap v1.0.12</td><td align="left" valign="bottom">pheatmap</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016418">SCR_016418</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R package velocyto.R v0.6</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">La Manno et al., 2018</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018167">SCR_018167</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cytoscape v3.10.1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib71">Shannon et al., 2003</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003032">SCR_003032</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">EnrichmentMap v3.3.6</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib53">Merico et al., 2010</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016052">SCR_016052</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">AutoAnnotate v1.4.1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Kucera et al., 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://apps.cytoscape.org/apps/autoannotate">https://apps.cytoscape.org/apps/autoannotate</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ v1.51</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GRatio for ImageJ</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib20">Goebbels et al., 2010</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015580">SCR_015580</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://gratio.efil.de/">http://gratio.efil.de/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism v5.01</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R v4.2.1</td><td align="left" valign="bottom">The R Project for Statistical Computing</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DMEM/High glucose</td><td align="left" valign="bottom">HyClone</td><td align="left" valign="bottom">Cat# SH30243.01</td><td align="left" valign="bottom">Medium used during FACS isolation of cells</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Horse serum, heat inactivated</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat# 26050â088</td><td align="left" valign="bottom">Serum used during FACS isolation of cells</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Collagenase, type 2</td><td align="left" valign="bottom">Worthington Biochemical</td><td align="left" valign="bottom">Cat# LS004177</td><td align="left" valign="bottom">Dissociation enzyme used during FACS isolation of cells</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Dispase II</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat# 17105â041</td><td align="left" valign="bottom">Dissociation enzyme used during FACS isolation of cells</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">HiSeq X Ten</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">Cat# SY-412â1001</td><td align="left" valign="bottom">scRNA-seq device</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TRRUST v2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib24">Han et al., 2018</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022554">SCR_022554</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.grnpedia.org/trrust/">https://www.grnpedia.org/trrust/</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">KEGG PATHWAY Database</td><td align="left" valign="bottom">Kanehisa Laboratories</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018145">SCR_018145</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/kegg/pathway.html">https://www.genome.jp/kegg/pathway.html</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">g:Profiler</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Kolberg et al., 2023</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006809">SCR_006809</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/gprofiler/gost">https://biit.cs.ut.ee/gprofiler/gost</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Isolated Pulse Stimulator</td><td align="left" valign="bottom">A-M Systems</td><td align="left" valign="bottom">Model 2100</td><td align="left" valign="bottom">Electric pulse generator used during CMAP measurement</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Data Recorder</td><td align="left" valign="bottom">iWorx</td><td align="left" valign="bottom">IX-RA-834</td><td align="left" valign="bottom">Data recorder used during CMAP measurement</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Ultramicrotome</td><td align="left" valign="bottom">Leica</td><td align="left" valign="bottom">EM UC7</td><td align="left" valign="bottom">Used for sciatic nerve semi-thin section generation</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Light microscope</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">EVOS FL Auto 2</td><td align="left" valign="bottom">Used for imaging toluidine blue-stained sciatic nerve sections</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>C57BL/6 J (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link>), <italic>Prrx1<sup>Cre</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005584">IMSR_JAX:005584</ext-link>), <italic>Bdnf<sup>fl</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004339">IMSR_JAX:004339</ext-link>), <italic>Plp1<sup>CreER</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005975">IMSR_JAX:005975</ext-link>), and <italic>Rosa26<sup>LSL-tdTomato</sup></italic> (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007914">IMSR_JAX:007914</ext-link>) mice were all obtained from The Jackson Laboratory. To generate <italic>Prrx1<sup>Cre</sup>; Bdnf<sup>fl/fl</sup></italic> mice, <italic>Prrx1<sup>Cre/+</sup>; Bdnf<sup>fl/+</sup></italic> males; and <italic>Bdnf<sup>fl/fl</sup></italic> females were crossed to avoid germline recombination in the female reproductive cells, and littermates were used as controls. To generate <italic>Plp1<sup>CreER</sup>; Rosa26<sup>LSL-tdTomato</sup></italic> mice, <italic>Plp1<sup>CreER/+</sup></italic> mice were crossed with <italic>Rosa26<sup>LSL-tdTomato/+</sup></italic> mice, and the line was kept by breeding <italic>Plp1<sup>CreER/+</sup>; Rosa26<sup>LSL-tdTomato/LSL-tdTomato</sup></italic> males; and females. Only mice that had the <italic>Plp1<sup>CreER</sup></italic> allele was used. Primers used for genotyping are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>. All mice were bred on the B6 background, except for the <italic>Prrx1<sup>Cre</sup>; Bdnf<sup>fl/fl</sup></italic> mice, and littermates that were kept in the mixed B6, 129S4, and BALB/c background. All mice were housed in a specific-pathogen-free (SPF) animal facility, with a 12 hr light/12 hr dark cycle at room temperature (RT, 22â) and 40â60% humidity, and were fed with a normal chow diet and water ad libitum. Tamoxifen administration, sciatic nerve crush injury, denervation, and intramuscular injection of GDNF or GDNF-blocking antibodies were all given to 3â4 month-old adult mice. When comparing aged mice versus adult mice, 24-month-old and 5â6 month-old mice were used, respectively. In all cases except for <italic>Plp1<sup>CreER</sup>; Rosa26<sup>LSL-tdTomato</sup></italic> mice, male mice were used for the experiments. No sex-specific differences were observed in experiments using <italic>Plp1<sup>CreER</sup>; Rosa26<sup>LSL-tdTomato</sup></italic> mice. All experimental procedures were approved by the Institutional Animal Care and Use Committee at Seoul National University and were carried out according to the guidelines provided.</p></sec><sec id="s4-2"><title>Tamoxifen administration</title><p>To label Schwann cells, 3-month-old <italic>Plp1<sup>CreER</sup>; Rosa26<sup>LSL-tdTomato</sup></italic> mice were administered orally with tamoxifen (20 mg/ml in corn oil, 160 mg/kg body weight; Sigma-Aldrich) three times every other day.</p></sec><sec id="s4-3"><title>Sciatic nerve injury</title><p>Mice were deeply anesthesized via intraperitoneal injection of Avertin (32 mg/ml, ~800 mg/kg; Sigma-Aldrich), and the incision site on the posterior side of the right hindlimb was shaved and depilated using surgical clippers and hair removal cream. After cleansing the incision site with 70% ethanol, the incision was made on the skin with surgical scissors, and the biceps femoris muscle was punctured open with fine-tip forceps to expose the sciatic nerve. For sciatic nerve crush injury, the exposed nerve was crushed with fine forceps for 30 s at the site just proximal to where the tibial, peroneal, and sural nerves branched out from the sciatic nerve. For denervation, ~5 mm of the sciatic nerve proximal from the crush injury site was cut and removed. The punctured biceps femoris muscle and skin were then sutured, and the incision site was sterilized with povidione-iodine.</p></sec><sec id="s4-4"><title>Intramuscular injection of GDNF</title><p>Tibialis anterior muscle and the two gastrocnemius muscles (GA, lateral, and medial) were each injected with 10 Î¼l of either PBS or recombinant mouse GDNF (10 Î¼g/ml, Sigma-Aldrich) using 31-gauge insulin syringes without damaging any innervating nerves. The injected muscles were then dissected 48 hr post-injection for isolation of FAPs and further analysis. Mice in the same litter were randomly selected for either PBS or recombinant mouse GDNF injection.</p></sec><sec id="s4-5"><title>Intramuscular injection of GDNF-blocking antibodies</title><p>Tibialis anterior muscle and the two gastrocnemius muscles (GA, lateral, and medial) were each injected with 10 Î¼g of either normal rabbit IgG (Sino Biological) or anti-GDNF antibodies (Alomone Labs) using 31-gauge insulin syringes 24 hr post-SNC. The injected muscles were then dissected 48 hr post-injection (72 hr post-injury) for isolation of FAPs and further analysis. Mice in the same litter were randomly selected for either IgG or anti-GDNF antibody injection.</p></sec><sec id="s4-6"><title>Isolation of FAPs, Schwann cells, and others</title><p>Isolation of muscle-resident FAPs, Schwann cells, and others was performed according to a previously reported protocol (<xref ref-type="bibr" rid="bib45">Liu et al., 2015</xref>) with minor modifications. Muscles indicated in each experiment were dissected, finely chopped with surgical scissors, and washed with 10% horse serum (Gibco), and DMEM (HyClone) for further dissociation. Enzymatic dissociation was carried out in 10% horse serum, DMEM containing collagenase II (800 U/ml, Worthington Biochemical) and dispase II (1.1 U/ml, Gibco) for 40 min at 37â with mild agitation, and mechanical dissociation was performed by trituration of the dissociated solution with a 20-gauge needle 10 times. After filtering the solution through a 40 Î¼m strainer, dissociated mononuclear single cells were stained with the following antibodies: APC anti-mouse CD31, APC anti-mouse CD45, PE anti-mouse TER-119, biotin anti-mouse CD106 (Vcam1) (Biolegend), and FITC anti-mouse Ly-6A/E (Sca1) (BD Pharmingen). 7-aminoactinomycin D (7-AAD, Sigma-Aldrich) was added to stain dead cells, and PE/Cy7 streptavidin was used to label Vcam1<sup>+</sup> cells. Gating strategies used for the isolation of each cell type were as follows: FAPs, 7-AAD<sup>-</sup>Ter119<sup>-</sup>CD31<sup>-</sup>CD45<sup>-</sup>Vcam1<sup>-</sup>Sca1<sup>+</sup>; MuSCs, 7-AAD<sup>-</sup>Ter119<sup>-</sup>CD31<sup>-</sup>CD45<sup>-</sup>Vcam1<sup>+</sup>Sca1<sup>-</sup>; lineage-positive cells, 7-AAD<sup>-</sup>Ter119<sup>-</sup>CD31<sup>+</sup>, or 7-AAD<sup>-</sup>Ter119<sup>-</sup>CD45<sup>+</sup>; double-negative cells, 7-AAD<sup>-</sup>Ter119<sup>-</sup>CD31<sup>-</sup>CD45<sup>-</sup>Vcam1<sup>-</sup>Sca1<sup>-</sup>. For Schwann cells, 7-AAD<sup>-</sup>tdTomato<sup>+</sup> cells were sorted from tamoxifen-administered <italic>Plp1<sup>CreER</sup>; Rosa26<sup>LSL-tdTomato</sup> Rosa26<sup>LSL-tdTomato</sup></italic> mice.</p></sec><sec id="s4-7"><title>scRNA-seq library construction and sequencing</title><p>FAPs were isolated from sciatic nerve crush injury-affected or denervated muscles on days 3, 7, 14, and 28 post-injury using wild-type B6 mice, so that a total of nine samples, including uninjured control, were collected for library generation. For each sample, isolated FAPs were pooled from two mice. Chromium Next GEM Single Cell 3Ê¹ Kit v3.1 (10x Genomics) was used according to the manufacturerâs instructions for the nine collected FAP samples, and the target cell number for recovery was set to 5000 in each sample. Sequencing of the libraries was carried out using HiSeq X Ten (Illumina).</p></sec><sec id="s4-8"><title>Computational analysis of scRNA-seq data</title><p>Sequenced reads were aligned to the mouse reference genome mm10 using CellRanger v3.1.0 (10x Genomics), and aligned reads were transformed into gene-cell count matrices using velocyto v0.17 (<xref ref-type="bibr" rid="bib40">La Manno et al., 2018</xref>) to obtain count matrices for both spliced and unspliced mRNAs. Output loom files were then loaded with R package SeuratWrappers v0.3.1, and were preprocessed and analyzed using R package Seurat v4.3.0 (<xref ref-type="bibr" rid="bib27">Hao et al., 2021</xref>) for downstream analysis. The preprocessing steps for quality control included doublet filtering, live cell filtering, and removal of non-FAPs as previously described (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>). All nine sample data were merged and normalized for dimensionality reduction, where the top eight principal components from the principal component analysis using 5000 variable genes were selected for two-dimensional UMAP embedding and visualization. Unsupervised clustering of cells was achieved through FindNeighbors and FindClusters functions in the Seurat R package. To identify DEGs in the pairwise comparisons of scRNA-seq samples, the FindMarkers function in Seurat R package was used with the following parameters: fold change â¥ 2, pseudocount.use=0.01, min.pct=0.01, adjusted <italic>&lt;</italic>i&gt;p-value &lt;0.05. For identification of DEGs in each cluster, the FindAllMarkers function was used with the parameters: fold change â¥ 1.5, pseudocount.use=0.01, min.pct=0.02, adjusted <italic>&lt;</italic>i&gt;p-value &lt;0.05. For hierarchical clustering, the R package pheatmap v1.0.12 was used. For RNA velocity analysis, R package velocyto.R v0.6 was used following the instructions provided by the developer (<xref ref-type="bibr" rid="bib40">La Manno et al., 2018</xref>). For the prediction of upstream regulatory transcription factors using lists of DEGs enriched in the selected FAP clusters, the web-based tool TRRUST v2 (<xref ref-type="bibr" rid="bib24">Han et al., 2018</xref>) was used. For color mapping of the MAPK signaling pathway, the pathway image from the KEGG PATHWAY Database (<xref ref-type="bibr" rid="bib35">Kanehisa et al., 2023</xref>) was retrieved and colored manually.</p></sec><sec id="s4-9"><title>Gene set overrepresentation analysis</title><p>To identify pathways enriched in the lists of DEGs, a web-based version of g:Profiler (<xref ref-type="bibr" rid="bib38">Kolberg et al., 2023</xref>) was used with the following parameters: organism â <italic>Mus musculus</italic>; ordered query â YES; data sources â GO biological process without electronic GO annotations, Reactome, and WikiPathways; advanced options were set to default. Visualization of the results were done as previously described (<xref ref-type="bibr" rid="bib64">Reimand et al., 2019</xref>), using the Cytoscape v3.10.1 (<xref ref-type="bibr" rid="bib71">Shannon et al., 2003</xref>) application with tools EnrichmentMap v3.3.6 (<xref ref-type="bibr" rid="bib53">Merico et al., 2010</xref>) and AutoAnnotate v1.4.1 (<xref ref-type="bibr" rid="bib39">Kucera et al., 2016</xref>).</p></sec><sec id="s4-10"><title>RNA extraction and qRT-PCR</title><p>Total RNA extraction and reverse transcription was carried out for isolated FAPs, Schwann cells, MuSCs, and others using TRIzol reagent (Invitrogen) and ReverTra Ace qPCR RT Master Mix (Toyobo) reagents respectively, following the manufacturerâs instructions. qPCR was performed using ORA SEE qPCR Green ROX L Mix (HighQu) reagent, with gene-specific primers listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>. Quantitative analysis of mRNA levels were done using the 2<sup>-ÎÎCt</sup> method with Î²-actin (<italic>Actb</italic>) as the housekeeping gene for normalization.</p></sec><sec id="s4-11"><title>Western blot analysis</title><p>FACS-isolated FAPs were lysed in RIPA buffer (Biosesang) added with 1 x Halt protease inhibitor cocktail (Thermo Scientific), and were sonicated. The lysate was then centrifuged at 13,000 rpm for 30 min at 4â, and the supernatant was mixed with Laemmli sample buffer before heating at 95â for 10 min. Samples were subjected to electrophoresis in 10% polyacrylamide gels and transferred to 0.45 Î¼m PVDF membranes (Immobilon). For GAPDH (rabbit anti-GAPDH, 1:1000, Bethyl Laboratories) and PDGFRÎ± (rabbit anti-PDGFRÎ±, 1:200, Santa Cruz Biotechnology), membranes were blocked in 5% skim milk (LPS Solution), 0.1% Tween-20 (Sigma-Aldrich) in TBS, and incubated with primary antibodies overnight at 4â, and then with the secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG, 1:10,000, Promega) for 1 hr at RT. For BDNF (rabbit anti-BDNF, 1:1000, Alomone Labs), membranes were blocked in 5% bovine serum albumin (Bovogen Biologicals), 0.1% Tween-20 in TBS, and incubated with the primary antibody in immunoreaction enhancer solution 1 (Toyobo) for 1 hr at RT, and then with the same secondary antibody in immunoreaction enhancer solution 2 (Toyobo) for 1 hr at RT. The membranes were then developed using SuperSignal West Dura Extended Duration Substrate (Thermo Scientific) according to the manufacturerâs instructions, and imaged with FUSION Solo chemiluminescence imaging system (Vilber Lourmat). Densitometric quantification of the imaged data were performed using ImageJ v1.51n (NIH).</p></sec><sec id="s4-12"><title>Electromyography and CMAP measurement</title><p>Intraperitoneal injection of Avertin (32 mg/ml,~800 mg/kg) for anesthetization of mice was carried out prior to CMAP measurement. Stimulation of the sciatic nerve was achieved by placing stimulating electrodes subcutaneously on either side of the sciatic notch and applying supramaximal stimuli (~70 mA) at a rate of 1 pulse per second with a duration of 0.1 ms, using Isolated Pulse Stimulator Model 2100 (A-M Systems). Recording electrode was placed carefully on the GA muscle subdermally without puncturing the muscle, with the reference electrode placed near the Achilles tendon and the ground electrode placed on the tail for data recording using Data Recorder IX-RA-834 (iWorx). CMAP amplitude was determined by the absolute difference between potentials of positive and negative peaks, and CMAP latency was determined by the delay from stimulus peak to the beginning of response peak. Three individual measurements were taken from each animalâs GA muscle, and average values were used as representatives for statistical analysis. The measurements were obtained by a single evaluator (K. Y.) blinded to the genotype.</p></sec><sec id="s4-13"><title>Toluidine blue staining of sciatic nerves</title><p>Sciatic nerve distal to the injury site was dissected at 6 weeks post-injury for analysis. The dissected nerves were fixed in 4% paraformaldehyde dissolved in Sorensenâs phosphate buffer (0.1 M, pH 7.2) at 4â overnight, followed by procedures described previously (<xref ref-type="bibr" rid="bib37">Kim et al., 2022</xref>) with minor modifications for semi-thin sectioning. Briefly, fixed samples were washed with 0.1 M sodium cacodylate buffer (pH 7.2), post-fixed with 1% osmium tetroxide in 0.1 M sodium cacodylate buffer (pH 7.2) for 1 hr at RT, washed with distilled water (DW) and stained with 0.5% uranyl acetate at 4â overnight. Stained samples were then washed with DW and dehydrated using serial ethanol and propylene oxide. Samples were then embedded in Spurrâs resin (Electron Microscopy Sciences), and semi-thin sections (500 nm) were prepared with a diamond knife on an ultramicrotome EM UC7 (Leica). The sections were dried down on glass slides for staining and light microscopy. Toluidine blue staining were done using 1% toluidine blue solution containing 1% sodium borate on a slide warmer (70â), and images were obtained with the light microscope EVOS FL Auto 2 (Thermo Fisher Scientific) for analysis.</p></sec><sec id="s4-14"><title>G-ratio quantification</title><p>Semi-automated quantification of myelinated axon diameters were carried out using an ImageJ plugin for g-ratio quantification (<xref ref-type="bibr" rid="bib20">Goebbels et al., 2010</xref>), where axon diameters and G-ratios were quantified and calculated, respectively. G-ratios were calculated as [naked axon diameter]/[myelinated axon diameter]. Selection of axons for quantification was randomized by the ImageJ plugin, and a single evaluator (K. Y.) performed the semi-automated quantification blinded to the genotype.</p></sec><sec id="s4-15"><title>Quantification and statistical analysis</title><p>All statistical analyses were performed using Prism v5.01 (GraphPad) and R v4.2.1. Continuous variables were tested for normal distribution with the Shapiro-Wilk test, and the F-test was used to check for equal variance. For comparison of significant differences in multiple groups, a one-way analysis of variance (ANOVA) followed by Bonferroniâs pairwise post hoc test was applied. For the comparison of the two groups, an unpaired t-test was used for data with normal distribution and equal variance; Welchâs t-test was used for data with normal distribution and unequal variance; and the Mann-Whitney U test was used for non-normally distributed data. ANCOVA was applied to test for differences between slopes of linear regression lines. Two-way ANOVA was applied to compare two groups with two variables. For comparison of gene expression levels between scRNA-seq data, the Wilcoxon rank sum test was applied as a default in functions FindAllMarkers and FindMarkers within the R package Seurat v4.3.0. For RT-qPCR, the average of triplicate technical values were used for each biological replicate. All error bars represent mean Â± SD. p-value of less than 0.05 was considered statistically significant at the 95% confidence level. The number of technical and biological replicates and statistical analyses used in each experiment are indicated in the figure legends.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Formal analysis, Validation, Investigation, Visualization, Writing â review and editing</p></fn><fn fn-type="con" id="con3"><p>Software, Validation</p></fn><fn fn-type="con" id="con4"><p>Resources</p></fn><fn fn-type="con" id="con5"><p>Resources</p></fn><fn fn-type="con" id="con6"><p>Resources, Writing â review and editing</p></fn><fn fn-type="con" id="con7"><p>Writing â review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources</p></fn><fn fn-type="con" id="con9"><p>Resources</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Validation</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition, Validation, Project administration, Writing â review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experimental procedures were approved by the Institutional Animal Care and Use Committtee at Seoul National University (Permit Numbers: SNU-200509-2-2, SNU-201202-1-3, SNU-210118-5-1, SNU-230415-1-1, SNU-231218-1) and were carried out according to the guidelines provided.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplemental tables showing results from TRRUST analyses, candidate effector gene categorization, and primer sequences used in this study.</title><p>(a) Results from TRRUST show transcription factors predicted to regulate genes specifically enriched in cluster 2. Genes known to be regulated by each transcription factor is listed. (b) Results from TRRUST showing transcription factors predicted to regulate genes specifically enriched in cluster 3. Genes known to be regulated by each transcription factor is listed. (c) Categorization of genes predicted to be regulated by transcription factors that act downstream of the glial cell line-derived neurotrophic factor (GDNF) signaling pathway. Note that only <italic>Bdnf</italic> fits into all three criteria. (d) Primers used in this study for genotyping PCR or RT-qPCR.</p></caption><media xlink:href="elife-97662-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-97662-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Single-cell RNA-sequencing data produced in this study have been deposited at GEO under accession number GSE250436. Study design, data analysis, and reporting the data were done according to the ARRIVE guidelines (<xref ref-type="bibr" rid="bib36">Kilkenny et al., 2010</xref>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>K</given-names></name><name><surname>Kong</surname><given-names>Y-Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Muscle-resident mesenchymal progenitors sense and repair peripheral nerve injury via the GDNF-BDNF axis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250436">GSE250436</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>MJ</given-names></name><name><surname>Toma</surname><given-names>JS</given-names></name><name><surname>Johnston</surname><given-names>AP</given-names></name><name><surname>Steadman</surname><given-names>PE</given-names></name><name><surname>Yuzwa</surname><given-names>SA</given-names></name><name><surname>Mahmud</surname><given-names>N</given-names></name><name><surname>Frankland</surname><given-names>PW</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Mesenchymal precursor cells in adult nerves contribute to mammalian tissue repair and regeneration</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120678">GSE120678</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Toma</surname><given-names>JS</given-names></name><name><surname>Karamboulas</surname><given-names>K</given-names></name><name><surname>Carr</surname><given-names>MJ</given-names></name><name><surname>Kolaj</surname><given-names>A</given-names></name><name><surname>Yuzwa</surname><given-names>SA</given-names></name><name><surname>Mahmud</surname><given-names>N</given-names></name><name><surname>Storer</surname><given-names>MA</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth (scRNAseq data)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147285">GSE147285</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Giger</surname><given-names>RJ</given-names></name><name><surname>Johnson</surname><given-names>CN</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Injured Sciatic Nerve Atlas (iSNAT)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE198582">GSE198582</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>PL</given-names></name><name><surname>Nicoletti</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Muscle denervation promotes functional interactions between glial and mesenchymal cells through NGFR and NGF</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221736">GSE221736</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Jong-Eun Park for his helpful comments on the analysis of our scRNA-seq data. <italic>Prrx1<sup>Cre</sup></italic> mice, <italic>Bdnf<sup>fl</sup></italic> mice, and <italic>Plp1<sup>CreER</sup></italic> mice were obtained via the Korea Mouse Phenotyping Center, deposited by Dr. Rho Hyun Seong, Dr. Yun-Hee Lee, and Dr. Myunghwan Choi, respectively. Also, we would like to acknowledge technical support from the Center for Research Facilities, Biological Sciences Department, Seoul National University (SNU), and SNU National Instrumentation Center for Environmental Management. Library construction and sequencing of the scRNA-seq data was performed by Macrogen Inc Experimental schemes and graphical summaries in this paper were created using BioRender. This work was supported by grants from the National Research Foundation of Korea (NRF-2020R1A5A1018081, NRF-2022R1A2C3007621) funded by the Korean government (MSIT).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Airaksinen</surname><given-names>MS</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The GDNF family: signalling, biological functions and therapeutic value</article-title><source>Nature Reviews. Neuroscience</source><volume>3</volume><fpage>383</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/nrn812</pub-id><pub-id pub-id-type="pmid">11988777</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur-Farraj</surname><given-names>PJ</given-names></name><name><surname>Latouche</surname><given-names>M</given-names></name><name><surname>Wilton</surname><given-names>DK</given-names></name><name><surname>Quintes</surname><given-names>S</given-names></name><name><surname>Chabrol</surname><given-names>E</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Woodhoo</surname><given-names>A</given-names></name><name><surname>Jenkins</surname><given-names>B</given-names></name><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Turmaine</surname><given-names>M</given-names></name><name><surname>Wicher</surname><given-names>GK</given-names></name><name><surname>Mitter</surname><given-names>R</given-names></name><name><surname>Greensmith</surname><given-names>L</given-names></name><name><surname>Behrens</surname><given-names>A</given-names></name><name><surname>Raivich</surname><given-names>G</given-names></name><name><surname>Mirsky</surname><given-names>R</given-names></name><name><surname>Jessen</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration</article-title><source>Neuron</source><volume>75</volume><fpage>633</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.06.021</pub-id><pub-id pub-id-type="pmid">22920255</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aurora</surname><given-names>AB</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immune modulation of stem cells and regeneration</article-title><source>Cell Stem Cell</source><volume>15</volume><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.06.009</pub-id><pub-id pub-id-type="pmid">24996166</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakooshli</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Monti</surname><given-names>E</given-names></name><name><surname>Su</surname><given-names>S</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Nalbandian</surname><given-names>M</given-names></name><name><surname>Alexandrova</surname><given-names>L</given-names></name><name><surname>Wheeler</surname><given-names>JR</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Blau</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase</article-title><source>Science Translational Medicine</source><volume>15</volume><elocation-id>eadg1485</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.adg1485</pub-id><pub-id pub-id-type="pmid">37820010</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baydyuk</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>BDNF signaling and survival of striatal neurons</article-title><source>Frontiers in Cellular Neuroscience</source><volume>8</volume><elocation-id>254</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00254</pub-id><pub-id pub-id-type="pmid">25221473</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BÃ¼ttner</surname><given-names>R</given-names></name><name><surname>Schulz</surname><given-names>A</given-names></name><name><surname>Reuter</surname><given-names>M</given-names></name><name><surname>Akula</surname><given-names>AK</given-names></name><name><surname>Mindos</surname><given-names>T</given-names></name><name><surname>Carlstedt</surname><given-names>A</given-names></name><name><surname>Riecken</surname><given-names>LB</given-names></name><name><surname>Baader</surname><given-names>SL</given-names></name><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Morrison</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammaging impairs peripheral nerve maintenance and regeneration</article-title><source>Aging Cell</source><volume>17</volume><elocation-id>e12833</elocation-id><pub-id pub-id-type="doi">10.1111/acel.12833</pub-id><pub-id pub-id-type="pmid">30168637</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>MJ</given-names></name><name><surname>Toma</surname><given-names>JS</given-names></name><name><surname>Johnston</surname><given-names>APW</given-names></name><name><surname>Steadman</surname><given-names>PE</given-names></name><name><surname>Yuzwa</surname><given-names>SA</given-names></name><name><surname>Mahmud</surname><given-names>N</given-names></name><name><surname>Frankland</surname><given-names>PW</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mesenchymal precursor cells in adult nerves contribute to mammalian tissue repair and regeneration</article-title><source>Cell Stem Cell</source><volume>24</volume><fpage>240</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.10.024</pub-id><pub-id pub-id-type="pmid">30503141</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JR</given-names></name><name><surname>Cosgaya</surname><given-names>JM</given-names></name><name><surname>Wu</surname><given-names>YJ</given-names></name><name><surname>Shooter</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Neurotrophins are key mediators of the myelination program in the peripheral nervous system</article-title><source>PNAS</source><volume>98</volume><fpage>14661</fpage><lpage>14668</lpage><pub-id pub-id-type="doi">10.1073/pnas.251543398</pub-id><pub-id pub-id-type="pmid">11717413</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>T</given-names></name><name><surname>Prasad</surname><given-names>K</given-names></name><name><surname>Lloyd</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Peripheral neuropathy: clinical and electrophysiological considerations</article-title><source>Neuroimaging Clinics of North America</source><volume>24</volume><fpage>49</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.nic.2013.03.023</pub-id><pub-id pub-id-type="pmid">24210312</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>CintrÃ³n-ColÃ³n</surname><given-names>AF</given-names></name><name><surname>Almeida-Alves</surname><given-names>G</given-names></name><name><surname>Boynton</surname><given-names>AM</given-names></name><name><surname>Spitsbergen</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GDNF synthesis, signaling, and retrograde transport in motor neurons</article-title><source>Cell and Tissue Research</source><volume>382</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s00441-020-03287-6</pub-id><pub-id pub-id-type="pmid">32897420</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>O</given-names></name><name><surname>Rebolledo</surname><given-names>DL</given-names></name><name><surname>OyarzÃºn</surname><given-names>JE</given-names></name><name><surname>OlguÃ­n</surname><given-names>HC</given-names></name><name><surname>Brandan</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis</article-title><source>Cell and Tissue Research</source><volume>364</volume><fpage>647</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1007/s00441-015-2343-0</pub-id><pub-id pub-id-type="pmid">26742767</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>O</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name><name><surname>Theret</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitors-time for new definitions</article-title><source>Skeletal Muscle</source><volume>11</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/s13395-021-00265-6</pub-id><pub-id pub-id-type="pmid">34210364</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Micheli</surname><given-names>AJ</given-names></name><name><surname>Laurilliard</surname><given-names>EJ</given-names></name><name><surname>Heinke</surname><given-names>CL</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Fraczek</surname><given-names>P</given-names></name><name><surname>Soueid-Baumgarten</surname><given-names>S</given-names></name><name><surname>De Vlaminck</surname><given-names>I</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Cosgrove</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis of the muscle stem cell hierarchy identifies heterotypic communication signals involved in skeletal muscle regeneration</article-title><source>Cell Reports</source><volume>30</volume><fpage>3583</fpage><lpage>3595</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.067</pub-id><pub-id pub-id-type="pmid">32160558</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doerflinger</surname><given-names>NH</given-names></name><name><surname>Macklin</surname><given-names>WB</given-names></name><name><surname>Popko</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Inducible site-specific recombination in myelinating cells</article-title><source>Genesis</source><volume>35</volume><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/gene.10154</pub-id><pub-id pub-id-type="pmid">12481300</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Encinas</surname><given-names>M</given-names></name><name><surname>Tansey</surname><given-names>MG</given-names></name><name><surname>Tsui-Pierchala</surname><given-names>BA</given-names></name><name><surname>Comella</surname><given-names>JX</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>1464</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-05-01464.2001</pub-id><pub-id pub-id-type="pmid">11222636</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>AW</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Nicolini</surname><given-names>JM</given-names></name><name><surname>Mulligan</surname><given-names>AM</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves</article-title><source>PNAS</source><volume>110</volume><fpage>16217</fpage><lpage>16222</lpage><pub-id pub-id-type="doi">10.1073/pnas.1303646110</pub-id><pub-id pub-id-type="pmid">24043773</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fielder</surname><given-names>GC</given-names></name><name><surname>Yang</surname><given-names>TW-S</given-names></name><name><surname>Razdan</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Perry</surname><given-names>JK</given-names></name><name><surname>Lobie</surname><given-names>PE</given-names></name><name><surname>Liu</surname><given-names>D-X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The GDNF Family: a role in cancer?</article-title><source>Neoplasia</source><volume>20</volume><fpage>99</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.neo.2017.10.010</pub-id><pub-id pub-id-type="pmid">29245123</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forese</surname><given-names>MG</given-names></name><name><surname>Pellegatta</surname><given-names>M</given-names></name><name><surname>Canevazzi</surname><given-names>P</given-names></name><name><surname>Gullotta</surname><given-names>GS</given-names></name><name><surname>Podini</surname><given-names>P</given-names></name><name><surname>Rivellini</surname><given-names>C</given-names></name><name><surname>Previtali</surname><given-names>SC</given-names></name><name><surname>Bacigaluppi</surname><given-names>M</given-names></name><name><surname>Quattrini</surname><given-names>A</given-names></name><name><surname>Taveggia</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prostaglandin D2 synthase modulates macrophage activity and accumulation in injured peripheral nerves</article-title><source>Glia</source><volume>68</volume><fpage>95</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1002/glia.23705</pub-id><pub-id pub-id-type="pmid">31479164</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Carnahan</surname><given-names>J</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Requirement for BDNF in activity-dependent survival of cortical neurons</article-title><source>Science</source><volume>263</volume><fpage>1618</fpage><lpage>1623</lpage><pub-id pub-id-type="doi">10.1126/science.7907431</pub-id><pub-id pub-id-type="pmid">7907431</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goebbels</surname><given-names>S</given-names></name><name><surname>Oltrogge</surname><given-names>JH</given-names></name><name><surname>Kemper</surname><given-names>R</given-names></name><name><surname>Heilmann</surname><given-names>I</given-names></name><name><surname>Bormuth</surname><given-names>I</given-names></name><name><surname>Wolfer</surname><given-names>S</given-names></name><name><surname>Wichert</surname><given-names>SP</given-names></name><name><surname>MÃ¶bius</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Lappe-Siefke</surname><given-names>C</given-names></name><name><surname>Rossner</surname><given-names>MJ</given-names></name><name><surname>Groszer</surname><given-names>M</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name><name><surname>Frahm</surname><given-names>J</given-names></name><name><surname>Boretius</surname><given-names>S</given-names></name><name><surname>Nave</surname><given-names>K-A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>8953</fpage><lpage>8964</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0219-10.2010</pub-id><pub-id pub-id-type="pmid">20592216</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>D</given-names></name><name><surname>Contreras</surname><given-names>O</given-names></name><name><surname>Rebolledo</surname><given-names>DL</given-names></name><name><surname>Espinoza</surname><given-names>JP</given-names></name><name><surname>van Zundert</surname><given-names>B</given-names></name><name><surname>Brandan</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ALS skeletal muscle shows enhanced TGF-Î² signaling, fibrosis and induction of fibro/adipogenic progenitor markers</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0177649</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0177649</pub-id><pub-id pub-id-type="pmid">28520806</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinsell</surname><given-names>D</given-names></name><name><surname>Keating</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies</article-title><source>BioMed Research International</source><volume>2014</volume><elocation-id>698256</elocation-id><pub-id pub-id-type="doi">10.1155/2014/698256</pub-id><pub-id pub-id-type="pmid">25276813</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammarberg</surname><given-names>H</given-names></name><name><surname>Piehl</surname><given-names>F</given-names></name><name><surname>Cullheim</surname><given-names>S</given-names></name><name><surname>Fjell</surname><given-names>J</given-names></name><name><surname>HÃ¶kfelt</surname><given-names>T</given-names></name><name><surname>Fried</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury</article-title><source>Neuroreport</source><volume>7</volume><fpage>857</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1097/00001756-199603220-00004</pub-id><pub-id pub-id-type="pmid">8724660</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Cho</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Yun</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Bae</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>CY</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>B</given-names></name><name><surname>Jeong</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Jeon</surname><given-names>HN</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Nam</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TRRUST v2</article-title><source>Nucleic Acids Research</source><volume>46</volume><elocation-id>D380</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkx1013</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hann</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>YL</given-names></name><name><surname>Jo</surname><given-names>YW</given-names></name><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Kong</surname><given-names>YY</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy</article-title><source>eLife</source><volume>12</volume><elocation-id>RP92731</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.92731</pub-id><pub-id pub-id-type="pmid">38318851</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanz</surname><given-names>S</given-names></name><name><surname>Perlson</surname><given-names>E</given-names></name><name><surname>Willis</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>JQ</given-names></name><name><surname>Massarwa</surname><given-names>R</given-names></name><name><surname>Huerta</surname><given-names>JJ</given-names></name><name><surname>Koltzenburg</surname><given-names>M</given-names></name><name><surname>Kohler</surname><given-names>M</given-names></name><name><surname>van-Minnen</surname><given-names>J</given-names></name><name><surname>Twiss</surname><given-names>JL</given-names></name><name><surname>Fainzilber</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Axoplasmic importins enable retrograde injury signaling in lesioned nerve</article-title><source>Neuron</source><volume>40</volume><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(03)00770-0</pub-id><pub-id pub-id-type="pmid">14687545</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heredia</surname><given-names>JE</given-names></name><name><surname>Mukundan</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>FM</given-names></name><name><surname>Mueller</surname><given-names>AA</given-names></name><name><surname>Deo</surname><given-names>RC</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration</article-title><source>Cell</source><volume>153</volume><fpage>376</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.02.053</pub-id><pub-id pub-id-type="pmid">23582327</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HÃ¶ke</surname><given-names>A</given-names></name><name><surname>Gordon</surname><given-names>T</given-names></name><name><surname>Zochodne</surname><given-names>DW</given-names></name><name><surname>Sulaiman</surname><given-names>OAR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation</article-title><source>Experimental Neurology</source><volume>173</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1006/exnr.2001.7826</pub-id><pub-id pub-id-type="pmid">11771940</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>S</given-names></name><name><surname>Wen</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Holst</surname><given-names>PL</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>M</given-names></name><name><surname>Tamir</surname><given-names>R</given-names></name><name><surname>Antonio</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Cupples</surname><given-names>R</given-names></name><name><surname>Louis</surname><given-names>JC</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Altrock</surname><given-names>BW</given-names></name><name><surname>Fox</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF</article-title><source>Cell</source><volume>85</volume><fpage>1113</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81311-2</pub-id><pub-id pub-id-type="pmid">8674117</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joe</surname><given-names>AWB</given-names></name><name><surname>Yi</surname><given-names>L</given-names></name><name><surname>Natarajan</surname><given-names>A</given-names></name><name><surname>Le Grand</surname><given-names>F</given-names></name><name><surname>So</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis</article-title><source>Nature Cell Biology</source><volume>12</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1038/ncb2015</pub-id><pub-id pub-id-type="pmid">20081841</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>NM</given-names></name><name><surname>Mukouyama</surname><given-names>YS</given-names></name><name><surname>Mosher</surname><given-names>JT</given-names></name><name><surname>Jaegle</surname><given-names>M</given-names></name><name><surname>Crone</surname><given-names>SA</given-names></name><name><surname>Dormand</surname><given-names>EL</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name><name><surname>Meijer</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells</article-title><source>Development</source><volume>131</volume><fpage>5599</fpage><lpage>5612</lpage><pub-id pub-id-type="doi">10.1242/dev.01429</pub-id><pub-id pub-id-type="pmid">15496445</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julier</surname><given-names>Z</given-names></name><name><surname>Park</surname><given-names>AJ</given-names></name><name><surname>Briquez</surname><given-names>PS</given-names></name><name><surname>Martino</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Promoting tissue regeneration by modulating the immune system</article-title><source>Acta Biomaterialia</source><volume>53</volume><fpage>13</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2017.01.056</pub-id><pub-id pub-id-type="pmid">28119112</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalinski</surname><given-names>AL</given-names></name><name><surname>Yoon</surname><given-names>C</given-names></name><name><surname>Huffman</surname><given-names>LD</given-names></name><name><surname>Duncker</surname><given-names>PC</given-names></name><name><surname>Kohen</surname><given-names>R</given-names></name><name><surname>Passino</surname><given-names>R</given-names></name><name><surname>Hafner</surname><given-names>H</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Kawaguchi</surname><given-names>R</given-names></name><name><surname>Carbajal</surname><given-names>KS</given-names></name><name><surname>Jara</surname><given-names>JS</given-names></name><name><surname>Hollis</surname><given-names>E</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Segal</surname><given-names>BM</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement</article-title><source>eLife</source><volume>9</volume><elocation-id>e60223</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60223</pub-id><pub-id pub-id-type="pmid">33263277</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Ishiguro-Watanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>KEGG for taxonomy-based analysis of pathways and genomes</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>D587</fpage><lpage>D592</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac963</pub-id><pub-id pub-id-type="pmid">36300620</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilkenny</surname><given-names>C</given-names></name><name><surname>Browne</surname><given-names>WJ</given-names></name><name><surname>Cuthill</surname><given-names>IC</given-names></name><name><surname>Emerson</surname><given-names>M</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research</article-title><source>Journal of Pharmacology &amp; Pharmacotherapeutics</source><volume>1</volume><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.4103/0976-500X.72351</pub-id><pub-id pub-id-type="pmid">21350617</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>JS</given-names></name><name><surname>Yoo</surname><given-names>K</given-names></name><name><surname>Jeong</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>I</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Jeon</surname><given-names>S</given-names></name><name><surname>Jo</surname><given-names>YW</given-names></name><name><surname>Hann</surname><given-names>SH</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>S</given-names></name><name><surname>Um</surname><given-names>SJ</given-names></name><name><surname>Seong</surname><given-names>RH</given-names></name><name><surname>Kong</surname><given-names>YY</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system</article-title><source>JCI Insight</source><volume>7</volume><elocation-id>e158380</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.158380</pub-id><pub-id pub-id-type="pmid">35603786</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>W207</fpage><lpage>W212</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad347</pub-id><pub-id pub-id-type="pmid">37144459</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucera</surname><given-names>M</given-names></name><name><surname>Isserlin</surname><given-names>R</given-names></name><name><surname>Arkhangorodsky</surname><given-names>A</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>AutoAnnotate: A Cytoscape app for summarizing networks with semantic annotations</article-title><source>F1000Research</source><volume>5</volume><elocation-id>1717</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.9090.1</pub-id><pub-id pub-id-type="pmid">27830058</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>Soldatov</surname><given-names>R</given-names></name><name><surname>Zeisel</surname><given-names>A</given-names></name><name><surname>Braun</surname><given-names>E</given-names></name><name><surname>Hochgerner</surname><given-names>H</given-names></name><name><surname>Petukhov</surname><given-names>V</given-names></name><name><surname>Lidschreiber</surname><given-names>K</given-names></name><name><surname>Kastriti</surname><given-names>ME</given-names></name><name><surname>LÃ¶nnerberg</surname><given-names>P</given-names></name><name><surname>Furlan</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Borm</surname><given-names>LE</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>van Bruggen</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Barker</surname><given-names>R</given-names></name><name><surname>SundstrÃ¶m</surname><given-names>E</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Kharchenko</surname><given-names>PV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA velocity of single cells</article-title><source>Nature</source><volume>560</volume><fpage>494</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0414-6</pub-id><pub-id pub-id-type="pmid">30089906</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leinroth</surname><given-names>AP</given-names></name><name><surname>Mirando</surname><given-names>AJ</given-names></name><name><surname>Rouse</surname><given-names>D</given-names></name><name><surname>Kobayahsi</surname><given-names>Y</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Rueckert</surname><given-names>HE</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Long</surname><given-names>JT</given-names></name><name><surname>Chakkalakal</surname><given-names>JV</given-names></name><name><surname>Hilton</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Identification of distinct non-myogenic skeletal-muscle-resident mesenchymal cell populations</article-title><source>Cell Reports</source><volume>39</volume><elocation-id>110785</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110785</pub-id><pub-id pub-id-type="pmid">35545045</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemos</surname><given-names>DR</given-names></name><name><surname>Babaeijandaghi</surname><given-names>F</given-names></name><name><surname>Low</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>CK</given-names></name><name><surname>Lee</surname><given-names>ST</given-names></name><name><surname>Fiore</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>RH</given-names></name><name><surname>Natarajan</surname><given-names>A</given-names></name><name><surname>Nedospasov</surname><given-names>SA</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors</article-title><source>Nature Medicine</source><volume>21</volume><fpage>786</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1038/nm.3869</pub-id><pub-id pub-id-type="pmid">26053624</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>B</given-names></name><name><surname>Kusi</surname><given-names>M</given-names></name><name><surname>Hung</surname><given-names>CN</given-names></name><name><surname>Chou</surname><given-names>CW</given-names></name><name><surname>He</surname><given-names>N</given-names></name><name><surname>Ho</surname><given-names>YY</given-names></name><name><surname>Taverna</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>THM</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Toward uncharted territory of cellular heterogeneity: advances and applications of single-cell RNA-seq</article-title><source>Journal of Translational Genetics and Genomics</source><volume>5</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.20517/jtgg.2020.51</pub-id><pub-id pub-id-type="pmid">34322662</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Thomas</surname><given-names>SS</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Decoding the transcriptome of denervated muscle at single-nucleus resolution</article-title><source>Journal of Cachexia, Sarcopenia and Muscle</source><volume>13</volume><fpage>2102</fpage><lpage>2117</lpage><pub-id pub-id-type="doi">10.1002/jcsm.13023</pub-id><pub-id pub-id-type="pmid">35726356</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Cheung</surname><given-names>TH</given-names></name><name><surname>Charville</surname><given-names>GW</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting</article-title><source>Nature Protocols</source><volume>10</volume><fpage>1612</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.110</pub-id><pub-id pub-id-type="pmid">26401916</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Lobe</surname><given-names>C</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer</article-title><source>Genesis</source><volume>33</volume><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/gene.10092</pub-id><pub-id pub-id-type="pmid">12112875</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukjanenko</surname><given-names>L</given-names></name><name><surname>Karaz</surname><given-names>S</given-names></name><name><surname>Stuelsatz</surname><given-names>P</given-names></name><name><surname>Gurriaran-Rodriguez</surname><given-names>U</given-names></name><name><surname>Michaud</surname><given-names>J</given-names></name><name><surname>Dammone</surname><given-names>G</given-names></name><name><surname>Sizzano</surname><given-names>F</given-names></name><name><surname>Mashinchian</surname><given-names>O</given-names></name><name><surname>Ancel</surname><given-names>S</given-names></name><name><surname>Migliavacca</surname><given-names>E</given-names></name><name><surname>Liot</surname><given-names>S</given-names></name><name><surname>Jacot</surname><given-names>G</given-names></name><name><surname>Metairon</surname><given-names>S</given-names></name><name><surname>Raymond</surname><given-names>F</given-names></name><name><surname>Descombes</surname><given-names>P</given-names></name><name><surname>Palini</surname><given-names>A</given-names></name><name><surname>Chazaud</surname><given-names>B</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name><name><surname>Bentzinger</surname><given-names>CF</given-names></name><name><surname>Feige</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Aging disrupts muscle stem cell function by impairing matricellular wisp1 secretion from fibro-adipogenic progenitors</article-title><source>Cell Stem Cell</source><volume>24</volume><fpage>433</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.12.014</pub-id><pub-id pub-id-type="pmid">30686765</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madaro</surname><given-names>L</given-names></name><name><surname>Passafaro</surname><given-names>M</given-names></name><name><surname>Sala</surname><given-names>D</given-names></name><name><surname>Etxaniz</surname><given-names>U</given-names></name><name><surname>Lugarini</surname><given-names>F</given-names></name><name><surname>Proietti</surname><given-names>D</given-names></name><name><surname>Alfonsi</surname><given-names>MV</given-names></name><name><surname>Nicoletti</surname><given-names>C</given-names></name><name><surname>Gatto</surname><given-names>S</given-names></name><name><surname>De Bardi</surname><given-names>M</given-names></name><name><surname>Rojas-GarcÃ­a</surname><given-names>R</given-names></name><name><surname>Giordani</surname><given-names>L</given-names></name><name><surname>Marinelli</surname><given-names>S</given-names></name><name><surname>Pagliarini</surname><given-names>V</given-names></name><name><surname>Sette</surname><given-names>C</given-names></name><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis</article-title><source>Nature Cell Biology</source><volume>20</volume><fpage>917</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0151-y</pub-id><pub-id pub-id-type="pmid">30050118</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magill</surname><given-names>CK</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>Kawamura</surname><given-names>D</given-names></name><name><surname>Hayashi</surname><given-names>A</given-names></name><name><surname>Hunter</surname><given-names>DA</given-names></name><name><surname>Parsadanian</surname><given-names>A</given-names></name><name><surname>Mackinnon</surname><given-names>SE</given-names></name><name><surname>Myckatyn</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reinnervation of the tibialis anterior following sciatic nerve crush injury: a confocal microscopic study in transgenic mice</article-title><source>Experimental Neurology</source><volume>207</volume><fpage>64</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2007.05.028</pub-id><pub-id pub-id-type="pmid">17628540</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maita</surname><given-names>KC</given-names></name><name><surname>Garcia</surname><given-names>JP</given-names></name><name><surname>Avila</surname><given-names>FR</given-names></name><name><surname>Torres-Guzman</surname><given-names>RA</given-names></name><name><surname>Ho</surname><given-names>O</given-names></name><name><surname>Chini</surname><given-names>CCS</given-names></name><name><surname>Chini</surname><given-names>EN</given-names></name><name><surname>Forte</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Evaluation of the aging effect on peripheral nerve regeneration: a systematic review</article-title><source>The Journal of Surgical Research</source><volume>288</volume><fpage>329</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2023.03.017</pub-id><pub-id pub-id-type="pmid">37060859</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malecova</surname><given-names>B</given-names></name><name><surname>Gatto</surname><given-names>S</given-names></name><name><surname>Etxaniz</surname><given-names>U</given-names></name><name><surname>Passafaro</surname><given-names>M</given-names></name><name><surname>Cortez</surname><given-names>A</given-names></name><name><surname>Nicoletti</surname><given-names>C</given-names></name><name><surname>Giordani</surname><given-names>L</given-names></name><name><surname>Torcinaro</surname><given-names>A</given-names></name><name><surname>De Bardi</surname><given-names>M</given-names></name><name><surname>Bicciato</surname><given-names>S</given-names></name><name><surname>De Santa</surname><given-names>F</given-names></name><name><surname>Madaro</surname><given-names>L</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3670</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06068-6</pub-id><pub-id pub-id-type="pmid">30202063</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallik</surname><given-names>A</given-names></name><name><surname>Weir</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Nerve conduction studies: essentials and pitfalls in practice</article-title><source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>76 Suppl 2</volume><fpage>ii23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2005.069138</pub-id><pub-id pub-id-type="pmid">15961865</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merico</surname><given-names>D</given-names></name><name><surname>Isserlin</surname><given-names>R</given-names></name><name><surname>Stueker</surname><given-names>O</given-names></name><name><surname>Emili</surname><given-names>A</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Enrichment map: A network-based method for gene-set enrichment visualization and interpretation</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e13984</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0013984</pub-id><pub-id pub-id-type="pmid">21085593</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>M</given-names></name><name><surname>Wacker</surname><given-names>K</given-names></name><name><surname>Ringelstein</surname><given-names>EB</given-names></name><name><surname>Hickey</surname><given-names>WF</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Kiefer</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Rapid response of identified resident endoneurial macrophages to nerve injury</article-title><source>The American Journal of Pathology</source><volume>159</volume><fpage>2187</fpage><lpage>2197</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)63070-2</pub-id><pub-id pub-id-type="pmid">11733369</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>MM</given-names></name><name><surname>Lawson</surname><given-names>JA</given-names></name><name><surname>Mathew</surname><given-names>SJ</given-names></name><name><surname>Hutcheson</surname><given-names>DA</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration</article-title><source>Development</source><volume>138</volume><fpage>3625</fpage><lpage>3637</lpage><pub-id pub-id-type="doi">10.1242/dev.064162</pub-id><pub-id pub-id-type="pmid">21828091</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Etxaniz</surname><given-names>U</given-names></name><name><surname>Proietti</surname><given-names>D</given-names></name><name><surname>Madaro</surname><given-names>L</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>scRNA-Seq-Based Analysis of Skeletal Muscle Response to Denervation Reveals Selective Activation of Muscle-Resident Glial Cells and Fibroblasts</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.12.29.424762</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Etxaniz</surname><given-names>U</given-names></name><name><surname>DâErcole</surname><given-names>C</given-names></name><name><surname>Madaro</surname><given-names>L</given-names></name><name><surname>Perera</surname><given-names>R</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Muscle denervation promotes functional interactions between glial and mesenchymal cells through NGFR and NGF</article-title><source>iScience</source><volume>26</volume><elocation-id>107114</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.107114</pub-id><pub-id pub-id-type="pmid">37416457</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oprescu</surname><given-names>SN</given-names></name><name><surname>Yue</surname><given-names>F</given-names></name><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Brito</surname><given-names>LF</given-names></name><name><surname>Kuang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Temporal dynamics and heterogeneity of cell populations during skeletal muscle regeneration</article-title><source>iScience</source><volume>23</volume><elocation-id>100993</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.100993</pub-id><pub-id pub-id-type="pmid">32248062</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-GÃ³mez</surname><given-names>A</given-names></name><name><surname>Perretti</surname><given-names>M</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Resolution of inflammation: an integrated view</article-title><source>EMBO Molecular Medicine</source><volume>5</volume><fpage>661</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1002/emmm.201202382</pub-id><pub-id pub-id-type="pmid">23592557</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oudega</surname><given-names>M</given-names></name><name><surname>Hagg</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord</article-title><source>Brain Research</source><volume>818</volume><fpage>431</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/s0006-8993(98)01314-6</pub-id><pub-id pub-id-type="pmid">10082829</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname><given-names>MW</given-names></name><name><surname>Brosius Lutz</surname><given-names>A</given-names></name><name><surname>Cheng</surname><given-names>YC</given-names></name><name><surname>Latremoliere</surname><given-names>A</given-names></name><name><surname>Duong</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>CM</given-names></name><name><surname>Posada</surname><given-names>S</given-names></name><name><surname>Cobos</surname><given-names>EJ</given-names></name><name><surname>Zhang</surname><given-names>AX</given-names></name><name><surname>Wagers</surname><given-names>AJ</given-names></name><name><surname>Havton</surname><given-names>LA</given-names></name><name><surname>Barres</surname><given-names>B</given-names></name><name><surname>Omura</surname><given-names>T</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration</article-title><source>Neuron</source><volume>83</volume><fpage>331</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.06.016</pub-id><pub-id pub-id-type="pmid">25033179</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrinello</surname><given-names>S</given-names></name><name><surname>Napoli</surname><given-names>I</given-names></name><name><surname>Ribeiro</surname><given-names>S</given-names></name><name><surname>Wingfield Digby</surname><given-names>P</given-names></name><name><surname>Fedorova</surname><given-names>M</given-names></name><name><surname>Parkinson</surname><given-names>DB</given-names></name><name><surname>Doddrell</surname><given-names>RDS</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Lloyd</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting</article-title><source>Cell</source><volume>143</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.08.039</pub-id><pub-id pub-id-type="pmid">20869108</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proietti</surname><given-names>D</given-names></name><name><surname>Giordani</surname><given-names>L</given-names></name><name><surname>De Bardi</surname><given-names>M</given-names></name><name><surname>DâErcole</surname><given-names>C</given-names></name><name><surname>Lozanoska-Ochser</surname><given-names>B</given-names></name><name><surname>Amadio</surname><given-names>S</given-names></name><name><surname>VolontÃ©</surname><given-names>C</given-names></name><name><surname>Marinelli</surname><given-names>S</given-names></name><name><surname>Muchir</surname><given-names>A</given-names></name><name><surname>BouchÃ©</surname><given-names>M</given-names></name><name><surname>Borsellino</surname><given-names>G</given-names></name><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name><name><surname>Madaro</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Activation of skeletal muscle-resident glial cells upon nerve injury</article-title><source>JCI Insight</source><volume>6</volume><elocation-id>e143469</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.143469</pub-id><pub-id pub-id-type="pmid">33661767</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimand</surname><given-names>J</given-names></name><name><surname>Isserlin</surname><given-names>R</given-names></name><name><surname>Voisin</surname><given-names>V</given-names></name><name><surname>Kucera</surname><given-names>M</given-names></name><name><surname>Tannus-Lopes</surname><given-names>C</given-names></name><name><surname>Rostamianfar</surname><given-names>A</given-names></name><name><surname>Wadi</surname><given-names>L</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Merico</surname><given-names>D</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap</article-title><source>Nature Protocols</source><volume>14</volume><fpage>482</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1038/s41596-018-0103-9</pub-id><pub-id pub-id-type="pmid">30664679</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>EW</given-names></name><name><surname>Deonarine</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>JO</given-names></name><name><surname>Denton</surname><given-names>AE</given-names></name><name><surname>Feig</surname><given-names>C</given-names></name><name><surname>Lyons</surname><given-names>SK</given-names></name><name><surname>Espeli</surname><given-names>M</given-names></name><name><surname>Kraman</surname><given-names>M</given-names></name><name><surname>McKenna</surname><given-names>B</given-names></name><name><surname>Wells</surname><given-names>RJB</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Caballero</surname><given-names>OL</given-names></name><name><surname>Larder</surname><given-names>R</given-names></name><name><surname>Coll</surname><given-names>AP</given-names></name><name><surname>OâRahilly</surname><given-names>S</given-names></name><name><surname>Brindle</surname><given-names>KM</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Tuveson</surname><given-names>DA</given-names></name><name><surname>Fearon</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Depletion of stromal cells expressing fibroblast activation protein-Î± from skeletal muscle and bone marrow results in cachexia and anemia</article-title><source>The Journal of Experimental Medicine</source><volume>210</volume><fpage>1137</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1084/jem.20122344</pub-id><pub-id pub-id-type="pmid">23712428</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Chikenji</surname><given-names>TS</given-names></name><name><surname>Matsumura</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name><name><surname>Fujimiya</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>889</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14734-x</pub-id><pub-id pub-id-type="pmid">32060352</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sariola</surname><given-names>H</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Novel functions and signalling pathways for GDNF</article-title><source>Journal of Cell Science</source><volume>116</volume><fpage>3855</fpage><lpage>3862</lpage><pub-id pub-id-type="doi">10.1242/jcs.00786</pub-id><pub-id pub-id-type="pmid">12953054</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheib</surname><given-names>J</given-names></name><name><surname>HÃ¶ke</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Advances in peripheral nerve regeneration</article-title><source>Nature Reviews. Neurology</source><volume>9</volume><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2013.227</pub-id><pub-id pub-id-type="pmid">24217518</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheib</surname><given-names>JL</given-names></name><name><surname>HÃ¶ke</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats</article-title><source>Neurobiology of Aging</source><volume>45</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.05.004</pub-id><pub-id pub-id-type="pmid">27459920</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>RW</given-names></name><name><surname>Arostegui</surname><given-names>M</given-names></name><name><surname>Schweitzer</surname><given-names>R</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name><name><surname>Underhill</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hic1 defines quiescent mesenchymal progenitor subpopulations with distinct functions and fates in skeletal muscle regeneration</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>797</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.11.004</pub-id><pub-id pub-id-type="pmid">31809738</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Research</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takemura</surname><given-names>Y</given-names></name><name><surname>Imai</surname><given-names>S</given-names></name><name><surname>Kojima</surname><given-names>H</given-names></name><name><surname>Katagi</surname><given-names>M</given-names></name><name><surname>Yamakawa</surname><given-names>I</given-names></name><name><surname>Kasahara</surname><given-names>T</given-names></name><name><surname>Urabe</surname><given-names>H</given-names></name><name><surname>Terashima</surname><given-names>T</given-names></name><name><surname>Yasuda</surname><given-names>H</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Matsusue</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Brain-derived neurotrophic factor from bone marrow-derived cells promotes post-injury repair of peripheral nerve</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e44592</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044592</pub-id><pub-id pub-id-type="pmid">23028564</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theret</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>FMV</given-names></name><name><surname>Contreras</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evolving roles of muscle-resident fibro-adipogenic progenitors in health, regeneration, neuromuscular disorders, and aging</article-title><source>Frontiers in Physiology</source><volume>12</volume><elocation-id>673404</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.673404</pub-id><pub-id pub-id-type="pmid">33959042</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toma</surname><given-names>JS</given-names></name><name><surname>Karamboulas</surname><given-names>K</given-names></name><name><surname>Carr</surname><given-names>MJ</given-names></name><name><surname>Kolaj</surname><given-names>A</given-names></name><name><surname>Yuzwa</surname><given-names>SA</given-names></name><name><surname>Mahmud</surname><given-names>N</given-names></name><name><surname>Storer</surname><given-names>MA</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Peripheral nerve single-cell analysis identifies mesenchymal ligands that promote axonal growth</article-title><source>eNeuro</source><volume>7</volume><elocation-id>ENEURO.0066-20.2020</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0066-20.2020</pub-id><pub-id pub-id-type="pmid">32349983</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treanor</surname><given-names>JJ</given-names></name><name><surname>Goodman</surname><given-names>L</given-names></name><name><surname>de Sauvage</surname><given-names>F</given-names></name><name><surname>Stone</surname><given-names>DM</given-names></name><name><surname>Poulsen</surname><given-names>KT</given-names></name><name><surname>Beck</surname><given-names>CD</given-names></name><name><surname>Gray</surname><given-names>C</given-names></name><name><surname>Armanini</surname><given-names>MP</given-names></name><name><surname>Pollock</surname><given-names>RA</given-names></name><name><surname>Hefti</surname><given-names>F</given-names></name><name><surname>Phillips</surname><given-names>HS</given-names></name><name><surname>Goddard</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>MW</given-names></name><name><surname>Buj-Bello</surname><given-names>A</given-names></name><name><surname>Davies</surname><given-names>AM</given-names></name><name><surname>Asai</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Vandlen</surname><given-names>R</given-names></name><name><surname>Henderson</surname><given-names>CE</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Characterization of a multicomponent receptor for GDNF</article-title><source>Nature</source><volume>382</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/382080a0</pub-id><pub-id pub-id-type="pmid">8657309</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trupp</surname><given-names>M</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Fainzilber</surname><given-names>M</given-names></name><name><surname>Nilsson</surname><given-names>AS</given-names></name><name><surname>Sieber</surname><given-names>BA</given-names></name><name><surname>Grigoriou</surname><given-names>M</given-names></name><name><surname>Kilkenny</surname><given-names>C</given-names></name><name><surname>Salazar-Grueso</surname><given-names>E</given-names></name><name><surname>Pachnis</surname><given-names>V</given-names></name><name><surname>ArumÃ¤e</surname><given-names>U</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Functional receptor for GDNF encoded by the c-ret proto-oncogene</article-title><source>Nature</source><volume>381</volume><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/381785a0</pub-id><pub-id pub-id-type="pmid">8657281</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Fukada</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle</article-title><source>Nature Cell Biology</source><volume>12</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1038/ncb2014</pub-id><pub-id pub-id-type="pmid">20081842</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Morikawa</surname><given-names>D</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Yoneda</surname><given-names>T</given-names></name><name><surname>Segawa</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>R</given-names></name><name><surname>Matev</surname><given-names>MM</given-names></name><name><surname>Miyagoe-Suzuki</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Tsujikawa</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Fukada</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle</article-title><source>Journal of Cell Science</source><volume>124</volume><fpage>3654</fpage><lpage>3664</lpage><pub-id pub-id-type="doi">10.1242/jcs.086629</pub-id><pub-id pub-id-type="pmid">22045730</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Ikemoto-Uezumi</surname><given-names>M</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle</article-title><source>Frontiers in Physiology</source><volume>5</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2014.00068</pub-id><pub-id pub-id-type="pmid">24605102</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uezumi</surname><given-names>A</given-names></name><name><surname>Ikemoto-Uezumi</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Kurosawa</surname><given-names>T</given-names></name><name><surname>Yoshimoto</surname><given-names>Y</given-names></name><name><surname>Nakatani</surname><given-names>M</given-names></name><name><surname>Hitachi</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Wakatsuki</surname><given-names>S</given-names></name><name><surname>Araki</surname><given-names>T</given-names></name><name><surname>Morita</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Toyoda</surname><given-names>M</given-names></name><name><surname>Kanazawa</surname><given-names>N</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Hino</surname><given-names>J</given-names></name><name><surname>Fukada</surname><given-names>SI</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mesenchymal Bmp3b expression maintains skeletal muscle integrity and decreases in age-related sarcopenia</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e139617</elocation-id><pub-id pub-id-type="doi">10.1172/JCI139617</pub-id><pub-id pub-id-type="pmid">33170806</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallecillo-GarcÃ­a</surname><given-names>P</given-names></name><name><surname>Orgeur</surname><given-names>M</given-names></name><name><surname>Vom Hofe-Schneider</surname><given-names>S</given-names></name><name><surname>Stumm</surname><given-names>J</given-names></name><name><surname>Kappert</surname><given-names>V</given-names></name><name><surname>Ibrahim</surname><given-names>DM</given-names></name><name><surname>BÃ¶rno</surname><given-names>ST</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Hildebrandt</surname><given-names>K</given-names></name><name><surname>Sengle</surname><given-names>G</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Timmermann</surname><given-names>B</given-names></name><name><surname>Marazzi</surname><given-names>G</given-names></name><name><surname>Sassoon</surname><given-names>DA</given-names></name><name><surname>Duprez</surname><given-names>D</given-names></name><name><surname>Stricker</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1218</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01120-3</pub-id><pub-id pub-id-type="pmid">29084951</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VerdÃº</surname><given-names>E</given-names></name><name><surname>Ceballos</surname><given-names>D</given-names></name><name><surname>Vilches</surname><given-names>JJ</given-names></name><name><surname>Navarro</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Influence of aging on peripheral nerve function and regeneration</article-title><source>Journal of the Peripheral Nervous System</source><volume>5</volume><fpage>191</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1111/j.1529-8027.2000.00026.x</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagstaff</surname><given-names>LJ</given-names></name><name><surname>Gomez-Sanchez</surname><given-names>JA</given-names></name><name><surname>Fazal</surname><given-names>SV</given-names></name><name><surname>Otto</surname><given-names>GW</given-names></name><name><surname>Kilpatrick</surname><given-names>AM</given-names></name><name><surname>Michael</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>LY</given-names></name><name><surname>Ma</surname><given-names>KH</given-names></name><name><surname>Turmaine</surname><given-names>M</given-names></name><name><surname>Svaren</surname><given-names>J</given-names></name><name><surname>Gordon</surname><given-names>T</given-names></name><name><surname>Arthur-Farraj</surname><given-names>P</given-names></name><name><surname>Velasco-Aviles</surname><given-names>S</given-names></name><name><surname>Cabedo</surname><given-names>H</given-names></name><name><surname>Benito</surname><given-names>C</given-names></name><name><surname>Mirsky</surname><given-names>R</given-names></name><name><surname>Jessen</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Failures of nerve regeneration caused by aging or chronic denervation are rescued by restoring Schwann cell c-Jun</article-title><source>eLife</source><volume>10</volume><elocation-id>e62232</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.62232</pub-id><pub-id pub-id-type="pmid">33475496</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>JC</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Cucoranu</surname><given-names>D</given-names></name><name><surname>Chmielewski</surname><given-names>S</given-names></name><name><surname>Holmes</surname><given-names>T</given-names></name><name><surname>Lau</surname><given-names>KS</given-names></name><name><surname>Bassell</surname><given-names>GJ</given-names></name><name><surname>English</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cooperative roles of BDNF expression in neurons and Schwann cells are modulated by exercise to facilitate nerve regeneration</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>5002</fpage><lpage>5009</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1411-11.2012</pub-id><pub-id pub-id-type="pmid">22492055</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wosczyna</surname><given-names>MN</given-names></name><name><surname>Konishi</surname><given-names>CT</given-names></name><name><surname>Perez Carbajal</surname><given-names>EE</given-names></name><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Walsh</surname><given-names>RA</given-names></name><name><surname>Gan</surname><given-names>Q</given-names></name><name><surname>Wagner</surname><given-names>MW</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle</article-title><source>Cell Reports</source><volume>27</volume><fpage>2029</fpage><lpage>2035</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.074</pub-id><pub-id pub-id-type="pmid">31091443</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>AW</given-names></name><name><surname>Willingham</surname><given-names>MM</given-names></name><name><surname>Kaasinen</surname><given-names>SK</given-names></name><name><surname>Hendry</surname><given-names>IA</given-names></name><name><surname>Howitt</surname><given-names>J</given-names></name><name><surname>Putz</surname><given-names>U</given-names></name><name><surname>Barrett</surname><given-names>GL</given-names></name><name><surname>Kilpatrick</surname><given-names>TJ</given-names></name><name><surname>Murray</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>BDNF exerts contrasting effects on peripheral myelination of NGF-dependent and BDNF-dependent DRG neurons</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>4016</fpage><lpage>4022</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3811-08.2009</pub-id><pub-id pub-id-type="pmid">19339597</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Rosen</surname><given-names>KM</given-names></name><name><surname>Hedstrom</surname><given-names>K</given-names></name><name><surname>Rey</surname><given-names>O</given-names></name><name><surname>Guha</surname><given-names>S</given-names></name><name><surname>Hart</surname><given-names>C</given-names></name><name><surname>Corfas</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway</article-title><source>Glia</source><volume>61</volume><fpage>1029</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1002/glia.22491</pub-id><pub-id pub-id-type="pmid">23553603</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JY</given-names></name><name><surname>Luo</surname><given-names>XG</given-names></name><name><surname>Xian</surname><given-names>CJ</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Zhou</surname><given-names>XF</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents</article-title><source>The European Journal of Neuroscience</source><volume>12</volume><fpage>4171</fpage><lpage>4180</lpage><pub-id pub-id-type="pmid">11122329</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>XF</given-names></name><name><surname>Huffman</surname><given-names>LD</given-names></name><name><surname>Hafner</surname><given-names>H</given-names></name><name><surname>Athaiya</surname><given-names>M</given-names></name><name><surname>Finneran</surname><given-names>MC</given-names></name><name><surname>Kalinski</surname><given-names>AL</given-names></name><name><surname>Kohen</surname><given-names>R</given-names></name><name><surname>Flynn</surname><given-names>C</given-names></name><name><surname>Passino</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>CN</given-names></name><name><surname>Kohrman</surname><given-names>D</given-names></name><name><surname>Kawaguchi</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>LJS</given-names></name><name><surname>Twiss</surname><given-names>JL</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Corfas</surname><given-names>G</given-names></name><name><surname>Giger</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The injured sciatic nerve atlas (iSNAT), insights into the cellular and molecular basis of neural tissue degeneration and regeneration</article-title><source>eLife</source><volume>11</volume><elocation-id>e80881</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.80881</pub-id><pub-id pub-id-type="pmid">36515985</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>BDNF promotes the axonal regrowth after sciatic nerve crush through intrinsic neuronal capability upregulation and distal portion protection</article-title><source>Neuroscience Letters</source><volume>621</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2016.04.006</pub-id><pub-id pub-id-type="pmid">27057731</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97662.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University Langone Medical Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group><kwd-group kwd-group-type="evidence-strength"><kwd>Incomplete</kwd><kwd>Solid</kwd></kwd-group></front-stub><body><p>The study has identified a cell type in muscle that is characterized as an adipogenic progenitor cell that is capable of promoting regeneration through the action of BDNF, a prominent growth factor regulated by GDNF in Schwann cells. These results represent an <bold>important</bold> cellular explanation for nerve regeneration. The revised analysis is <bold>solid</bold> but the work remains <bold>incomplete</bold> due to a lack of evidence that BDNF is produced during the process through the action of GDNF.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97662.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>In this manuscript, Yoo et al describe the role of a specialized cell type found in muscle, Fibro-adipogenic progenitors (FAPs), in promoting regeneration following sciatic nerve injury. Using single-cell transcriptomics, they characterize the expression profiles of FAPs at various times after nerve crush or denervation. Their results reveal that a population of these muscle-resident mesenchymal progenitors up regulate the receptors for GDNF, which is secreted by Schwann cells following crush injury, suggesting that FAPs respond to this growth factor. They also find that FAPs increase expression of BDNF, which promotes nerve regeneration. The authors demonstrate FAP production of BDNF in vivo is up regulated in response to injection of GDNF and that conditional deletion of BDNF in FAPs results in delayed nerve regeneration after crush injury, primarily due to lagging remyelination. Finally, they also find reduced BDNF expression following crush injury in aged mice, suggesting a potential mechanism to explain the decrease in peripheral nerve regenerative capability in aged animals. These results are very interesting and novel and provide important insights into the mechanisms regulating peripheral nerve regeneration, which has important clinical implications for understanding and treating nerve injuries.</p><p>However, the authors should provide more compelling evidence that BDNF is produced by FAPs in response to GDNF signaling. The suggestion that Schwann cell-derived GDNF is responsible for up regulation of BDNF in the FAPs is primarily indirect, based on the data showing that injection of GDNF into the muscle is sufficient to up regulate BDNF (Fig. 4H). The authors more directly test their hypothesis by administering GDNF blocking antibody and find a trend toward reduced BDNF (Fig. 4S2), but it is not statistically significant at this point. Additional replicates should be performed to determine if BDNF levels are indeed reduced when GDNF is blocked.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97662.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yoo</surname><given-names>Kyusang</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Jo</surname><given-names>Young-Woo</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Yoo</surname><given-names>Takwon</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Hann</surname><given-names>Sang-Hyeon</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Inkuk</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Yea-Eun</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ye Lynne</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Rhee</surname><given-names>Joonwoo</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>In-Wook</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ji-Hoon</given-names></name><role specific-use="author">Author</role><aff><institution>Korea Institute of Science and Technology</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Baek</surname><given-names>Daehyun</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kong</surname><given-names>Young-Yun</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authorsâ response to the original reviews.</p><p>Point-by-point reply in response to the Reviewerâs comments</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1</bold></p><p><bold>Public review:</bold></p><p>[1] (a) Given that only a fraction of the FAPs express BDNF after injury, the authors need to demonstrate the specificity of the Prrx1-Cre for FAPs. This is particularly important because muscle stem cell also express GDNF receptors (Fig. 3C &amp; D) and myogenic progenitors/satellite cells produce BDNF after nerve injury (Griesbeck et al., 1995 (PMID 8531223); Omura et al., 2005 (PMID 16221288)). (b) Moreover, as the authors point out, there are multipotent mesenchymal precursor cells in the nerve that migrate into the surrounding tissue following nerve injury and contribute to regeneration (Carr et al, PMID 30503141). Therefore, there are multiple possible sources of BDNF, highlighting the need to clearly demonstrate that FAP-derived BDNF is essential.</p></disp-quote><p>- (a) As the Reviewer noted, both GDNF receptor expression and increased BDNF expression in response to nerve injury are detectable in both FAPs and muscle stem cells (MuSCs). Therefore, we agree with the Reviewer that demonstrating the specificity of Prrx1-Cre in FAPs is crucial to support our claim. In our previous publication (Kim et al., 2022), using Prrx1-Cre; Rosa-eYFP mice, we showed that while most of the CD31-CD45-Vcam1-Sca1+ FAPs are eYFP+, CD31-CD45-Vcam1+Sca1- MuSCs do not express eYFP (Liu et al., 2015; Kim et al., 2022) (Attached Figure 1). Additionally, genomic DNA PCR using mononuclear cells sorted from our <italic>Prrx1Cre</italic>; <italic>Bdnffl/fl</italic> mice showed that DNA recombination in the floxed <italic>Bdnf</italic> gene could only be detected in FAPs and CD31-CD45-Vcam1-Sca1- cells, but not in MuSCs (Author response image 2). This is consistent with a previous report that showed Prrx1-Cre activity in FAPs, pericytes, vascular smooth muscle cells (vSMCs) and tenocytes (Leinroth et al., 2022), where pericytes, vSMCs and tenocytes are included the CD31-CD45-Vcam1Sca1- population (Giordani et al., 2019). Together, these results demonstrate that while Prrx1-Cre is active in FAPs, it is absent in MuSCs.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Expression of eYFP in muscle-resident, lineage-negative, live mononuclear cells isolated from <italic>Prrx1Cre</italic>;<italic>RosaeYFP</italic> mice.</title><p>Supplemental Figure 3A from Kim et al., 2022. Lin-: lineage-negative (CD31-CD45-); Neg.: Vcam1-Sca1-.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-sa2-fig1-v1.tif"/></fig><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Recombination of the floxed <italic>Bdnf</italic> gene in the mononuclear cells sorted from muscles of <italic>Prrx1Cre</italic>; <italic>Bdnffl/fl</italic> or <italic>Bdnffl/fl</italic> mice.</title><p>Genotypes and cell types sampled for each lane is specified. P4, P5, and P6 indicate primers used for each PCR. Lin+: lineage(CD31/CD45)-positive; DN: CD31-CD45-Vcam1-Sca1-.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-sa2-fig2-v1.tif"/></fig><p>- (b) We appreciate and agree with the Reviewerâs comment that additional experiments are needed to confirm that FAP-derived BDNF is indeed essential for nerve regeneration, considering other potential cellular sources of BDNF, such as nerve-resident mesenchymal precursor cells. One possible experiment that could demonstrate the requirement of FAP-derived BDNF in nerve regeneration would be the transplantation of wild-type FAPs into our <italic>Prrx1Cre</italic>; <italic>Bdnf fl/fl</italic> mice and to see if the delay in nerve regeneration and remyelination is recovered, making the process similar to that in control mice. Unfortunately, since the genetic background of our <italic>Prrx1Cre</italic>; <italic>Bdnffl/fl</italic> mice is a mixture of B6, 129S4, and BALB/c, immune rejection of the transplanted cells may occur, which makes the experiment technically difficult. Another experimental approach could involve the use of FAP-specific Cre mouse line, as we have mentioned in the Discussion of our original manuscript. However, such a line does not yet exist due to the lack of a marker gene that is expressed specifically in FAPs, but not in nerve-resident mesenchymal precursor cells. Overcoming such technical challenges and demonstrating the requirement of FAP-derived BDNF in nerve regeneration would significantly strengthen our report, though we regret that these methods are currently unavailable.</p><disp-quote content-type="editor-comment"><p>[2] Similarly, the authors should provide some evidence that BDNF protein is produced by FAPs. All of their data for BDNF expression is based on mRNA expression and that appears to only be increased in a small subset of FAPs. Perhaps an immunostaining could be done to demonstrate up-regulation of BDNF in FAPs after injury.</p></disp-quote><p>- We appreciate the Reviewerâs constructive comment. To demonstrate that BDNF protein is produced by FAPs upon nerve injury, we performed western blot analysis. FAPs were isolated from either sciatic nerve crush injury-affected muscles at 7 days post injury (dpi) or from the contralateral, uninjured muscles, and protein samples were prepared for SDS-PAGE and western blot using anti-BDNF, anti-PDGFRÎ± and antiGAPDH antibodies. As a result, while both nerve injury-affected and uninjured musclederived FAPs expressed PDGFRÎ±, the mature from of BDNF protein was only detected in nerve injury-affected FAPs, showing that BDNF is indeed expressed in FAPs at the protein level after injury. We have added this new result as Figure 4F in the New Figure 4 with the experimental scheme as New Figure 4âfigure supplement 1, and revised the Results section (lines 364-374) and the Materials and Methods section (lines 687-705) in our manuscript to include the new results in detail.</p><disp-quote content-type="editor-comment"><p>[3] The suggestion that Schwann cell-derived GDNF is responsible for upregulation of BDNF in the FAPs is indirect, based largely on the data showing that injection of GDNF into the muscle is sufficient to up-regulate BDNF (Fig. 4F &amp; G). However, to more directly connect the 2 observations in a causal way, the authors should inject a Ret/GDNF antagonist, such as a Ret-Fc construct, then measure the BDNF levels.</p></disp-quote><p>- We appreciate the Reviewerâs constructive comment, and we agree that testing the necessity of GDNF/RET signaling in BDNF upregulation is crucial to link the expression of the two neurotrophic factors in a causal way. As a means to antagonize GDNF/RET signaling, we injected anti-GDNF antibodies into the tibialis anterior and gastrocnemius muscles following sciatic nerve crush injury to block the activity of intramuscular GDNF protein. As a result, although the differences were not statistically significant, we observed a tendancy towards decreased <italic>Bdnf</italic> mRNA expression upon anti-GDNF injection compared to IgG controls. We have added this new result as New Figure 4âfigure supplement 2, and revised our manuscript to include the details in both the Results section (lines 381-390) and the Materials and Methods section (lines 611-616). We have also changed the title of New Figure 4 (line 332) to encompass the new results. We are aware that further experiments that may involve increasing the number of animals tested, increasing the antibody injection dosage or frequency, or implementation of genetic models such as <italic>Plp1CreER</italic>; <italic>Gdnffl/fl</italic> should be carried out to validate our hypothesis with statistical significance. Unfortunately, due to limited time, resources, and research funds, we were unable to perform such additional experiments. We hope that the Reviewer understands these limitations.</p><disp-quote content-type="editor-comment"><p>[4] (a) In assessing the regeneration after nerve crush, the authors focus on remyelination, for example, assessing CMAP and g-ratios. However, they should also quantify axon regeneration, which can be done distal to the crush injury at earlier time points, before the 6 weeks scored in their study. Evaluating axon regeneration, which occurs prior to remyelination, would be especially useful because BDNF can act on both Schwann cells, to promote myelination, and axons, enhancing survival and growth. (b) They could also evaluate the stability of the neuromuscular junctions, particularly if a denervation was done with the conditional knock outs, although that may be a bit beyond the scope of this study.</p></disp-quote><p>- (a) As the Reviewer mentioned, BDNF is known to act on both Schwann cells and axons, where it promotes myelination and axonal growth, respectively (Oudega and Hagg, 1998; Zhang et al., 2000; Chan et al., 2001; Xiao et al., 2009; English et al., 2013). We fully agree with the Reviewerâs comment that quantification of axon regeneration, which could be achieved through immunostaining of the distal part of the sciatic nerve at earlier time points after injury, would shed light on whether FAPderived BDNF can also contribute to axon regeneration in addition to remyelination. Unfortunately, we could not perform such additional experiments within the limited time frame, since preparing enough numbers of control and conditional knockout mice that match the age groups used in this study (3-4 months old), followed by waiting for additional 2-4 weeks after nerve crush injury for sample collection, and subsequent immunostaining for quantification could take almost 6 months in total. We hope that the Reviewer understands this limitation.</p><p>- (b) We appreciate the Reviewerâs constructive comment. Although the number of animals used for neuromuscular junction (NMJ) analyses was not sufficient, we had briefly examined the structure of NMJs at 4 weeks post nerve crush injury in control (Ctrl) and conditional knockout (cKO) mice as a preliminary experiment. As a result, no significant differences were observed between Ctrl and cKO mice in terms of NMJ morphology and innervation (Author response image 3).</p><fig id="sa2fig3" position="float"><label>Author response image 3.</label><caption><title>Structures of neuromuscular junctions from Ctrl vs cKO mice at 4 weeks post nerve crush injury.</title><p>Whole-mount immunostaining was done using the exterior digitorum longus muscles that were affected by sciatic nerve crush injury. Samples were stained with Î±-bungarotoxin (green), neurofilament (red), and synaptophysin (blue). Scale bar: 50 Î¼m.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97662-sa2-fig3-v1.tif"/></fig><p>Going back to part (a) of this Reviewerâs comment, considering the data presented in Author response image 3, where innervation of axons into acetylcholine receptor clusters was not significantly different between Ctrl versus cKO mice, FAP-derived BDNF may not be critical for the axonal growth upon nerve injury. Although we acknowledge that additional experiments are required to draw a meaningful conclusion on this point, we could not perform such additional experiments due to insufficient time and resources.</p><p>We hope that the Reviewer understands our limitation.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p>[1] In citing the ability of BDNF to promote Schwann cell myelination the authors should include Chan et al., 2001 (PMID 11717413) in addition to the Zhang et al, 2000 and Xiao et al, 2009 references.</p></disp-quote><p>- We apologize for missing out the reference mentioned by the Reviewer. We have added the suggested reference in our revised manuscript (lines 395, 425, and 517).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2</bold></p><p><bold>Public review:</bold></p><p>[1] Although, I find the data the authors generated enough for their claims. I do see them as relatively poor, and (a) a complementary analysis of protein expression would strengthen the paper through immunostaining of the different genes mentioned for FAPs and Schwann cells. The model is entirely supported by measuring mRNA levels and negative regulation of gene expression in specific cells. Additionally, (b) what happens to the structure of the neuromuscular junction after regeneration when GDNF or BDNF expression is reduced? (c) The determination of decreasing levels of FAPs BDNF mRNA during aging is interesting; is the gain of BDNF expression in FAPs reverting the phenotype?</p></disp-quote><p>- (a) We appreciate and agree with the Reviewerâs comment that validation of BDNF protein expression in FAPs and GDNF protein expression in Schwann cells upon nerve injury would strengthen this paper. Regarding GDNF protein expression in Schwann cells upon nerve injury, it has already been demonstrated by previous studies (HÃ¶ke et al., 2002; Xu et al., 2013). For BDNF protein expression in FAPs upon nerve injury, we performed western blot analysis for validation, as mentioned in the response to Reviewer #1 Public review [2]. The results showed that while the mature form of BDNF protein could not be readily detected in FAPs isolated from uninjured muscles, it could be detected in FAPs isolated from sciatic nerve crush injury-affected muscles at 7 days post injury. We have added the new result as Figure 4F in the New Figure 4 with the experimental scheme as New Figure 4âfigure supplement 1, and revised the Results section (lines 364-374) and the Materials and Methods section (lines 687-705) in our manuscript to include the new results in detail.</p><p>- (b) Though the data is preliminary, we examined the structures of neuromuscular junctions (NMJs) from control and <italic>Prrx1Cre</italic>; <italic>Bdnf fl/fl</italic> mice at 4 weeks post injury in the exterior digitorum longus muscles, as mentioned in the response to Reviewer #1 Publilc review [4](b). As a result, we could not identify significant differences between control versus <italic>Prrx1Cre</italic>; <italic>Bdnf fl/fl</italic> mice, where BDNF expression is reduced specifically in <italic>Prrx1</italic>-expressing cells, including FAPs (Attached Figure 3). Since other cellular sources of BDNF, such as Schwann cells, exist, regeneration of the NMJs may not have been as significantly affected as remyelination in our <italic>Prrx1Cre</italic>; <italic>Bdnf fl/fl</italic> mice. However, further experiments with a sufficient number of mice and more observation time points are required to statistically validate this hypothesis in detail. Unfortunately, preparing samples for such additional analyses would take more than four months, as we need to produce sufficient numbers of control and <italic>Prrx1Cre</italic>; <italic>Bdnf fl/fl</italic> mice that match the age groups used in this study. We hope that the Reviewer understands our limitation.</p><p>Regarding analyzing NMJ structures after regeneration affected by reduced GDNF levels, using genetic models such as <italic>Plp1CreER</italic>; <italic>Gdnffl/fl</italic> mice would be appropriate, as we have used the <italic>Prrx1Cre</italic>; <italic>Bdnffl/fl</italic> mice in this study to reduce BDNF levels produced by FAPs. Unfortunately, we do not have the <italic>Gdnffl</italic> mice, and obtaining these mice to produce <italic>Plp1CreER</italic>; <italic>Gdnffl/fl</italic> mice and performing the additional experiment would take too much time for this current revision. In a further study, we will try to perform the additional experiment by obtaining the required mouse line. We hope that the Reviewer understands our limitation.</p><p>- (c) We appreciate the Reviewer for highlighting this point. In this paper, we have shown that BDNF expression upon nerve injury is decreased in aged FAPs compared to young adult FAPs, and suggested that this may be one of the causes of the delayed nerve regeneration phenotype in aged mice. Previously, it has been reported that while intramuscular injection of BDNF accelerates nerve regeneration, intramuscular injection of anti-BDNF antibodies delays the regeneration process (Zheng et al., 2016). This implies that intramuscular levels of active BDNF can significantly influence the speed of nerve regeneration. Therefore, the gain of BDNF expression in aged FAPs may contribute to reversing the delayed nerve regeneration phenotype in aged mice, since it would result in additional supply of active, intramuscular BDNF, which has previously been shown to accelerate nerve regeneration. Though experimental validation is required to support such claim, we could not obtain sufficient numbers of aged mice within the limited time frame. We hope that the Reviewer understands our limitation.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p>[1] The authors should include the experimental design and several drawings in the leading figures indicating, for example, how remyelination after injury was quantified and how the response of regenerated sciatic nerve to a depolarizing stimulus was studied.</p></disp-quote><p>- We apologize for any confusion caused by insufficient information provided in the leading figures. Unfortunately, due to limited space, we could not add experimental designs or drawings in the leading figures. Instead, to do our best to comply with the</p><p>Reviewerâs comment, we have revised the figure legends in the leading figures so that the experimental designs or diagrams can be referred to in the figure supplements.</p><p>We hope that the Reviewer understands this limitation.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3</bold></p><p>Public review:</p><p>[1] In Fig. 1 and 2 authors provide data on scRNA seq and this is important information reporting the finding of RET and GFRa1 transcripts in the subpopulation of FAP cells. However, authors provide no data on the expression of RET and GFRa1 proteins in FAP cells.</p></disp-quote><p>- Reply for this comment by the Reviewer is in the Recommendations for the authors section below ([2]), as the same comment is repeated.</p><disp-quote content-type="editor-comment"><p>[2] Another problem is the lack of information showing that GDNF secreted by Schwann cells can activate RET and its down-stream signaling in FAP cells. There is no direct experimental proof that GDNF activating GFRa1-RET signaling triggers BDNF upregulation In FAP cells. The data that GDNF signaling is inducing the synthesis and secretion of BDNF is also not conclusive.</p></disp-quote><p>- Reply for this comment by the Reviewer is in the Recommendations for the authors section below ([3]), as the same comment is repeated.</p><disp-quote content-type="editor-comment"><p>Recommendations for the authors:</p><p>[1] Although this is a novel study and contains very well-performed parts, the GDNF section is preliminary and requires additional experimentation. In the introduction authors describe well FAPs but even do not mention how GDNF is signaling. Moreover, the reader may get an impression that Ras-MAPK pathway is the only or at least the main GDNF signaling pathway. In fact, for neurons Akt and Src signaling pathways play also crucial role.</p></disp-quote><p>- We apologize for the missing content in the Introduction section of our manuscript and for any confusion caused by our misleading description of the GDNF signaling pathway. We have revised our manuscript to include the GDNF signaling pathway in the Introduction section, along with a description of other downstream signaling pathways of GDNF that are known to play crucial roles, as mentioned by the Reviewer (lines 115-130). Additionally, we changed the expression in the Results section to avoid making any misleading impressions (lines 318-319).</p><disp-quote content-type="editor-comment"><p>[2] In Fig. 1 and 2 authors provide data on scRNA seq and this is important information reporting the finding of RET and GFRa1 transcripts in the subpopulation of FAP cells. However, authors provide no data on the expression of RET and GFRa1 proteins in FAP cells.</p></disp-quote><p>- We appreciate the Reviewer for the constructive comment. Though we fully agree with the Reviewer that validating the expression of RET and GFRÎ±1 proteins in FAPs is needed, we were unable to obtain the antibodies required for such experiments within the limited time frame for this revision. We hope that the Reviewer understands our limitation. Although we could not directly show the expression of those GDNF receptor genes at the protein level in FAPs, based on the result where intramuscular GDNF injection could sufficiently induce <italic>Bdnf</italic> expression in FAPs compared to PBS control in the absence of nerve damage, it is likely that GDNF receptors are indeed expressed at the protein level in FAPs, since if otherwise, FAPs would not have been able to respond to the injected GDNF protein. Nevertheless, in a future study, we will try to validate the protein-level expression of GDNF receptors in FAPs to comply with the Reviewerâs suggestion and to further support this study.</p><disp-quote content-type="editor-comment"><p>[3] Another problem is the lack of information showing that GDNF secreted by Schwann cells can activate RET and its down-stream signaling in FAP cells. Authors can monitor activation of MAPK pathway by detecting phospho-Erk and PI3 kinase-Akt pathway measuring phospho-S6 using immunohistochemistry. We can recommend to use the following antibodies: pErk1/2 (1:300, Cell Signaling, Cat# 4370L RRID:AB_2297462), pS6 (1:300, Cell Signaling, Cat# 4858L RRID:AB_1031194). These experiments are crucial because RET and GFRa1 proteins maybe not expressed at the sufficient level on the cell surface.</p></disp-quote><p>- We sincerely appreciate the Reviewerâs constructive comment. In this study, we suggested that the GDNF-BDNF axis within FAPs would signal through the MAPK pathway based on the bioinformatic analysis of our single cell RNA-seq data and matching the results with the previously known pathways. We fully agree that monitoring the activation of the MAPK pathway and the PI3K-Akt pathway by immunohistochemistry would experimentally demostrate whether GDNF can activate those pathways within FAPs through GFRÎ±1/RET activation. Unfortunately, we could not obtain the antibodies suggested by the Reviewer for this revision due to insufficient research funds and limited time frame. We hope that the Reviewer understands our limitation. In future studies, we will try to validate the detailed molecular pathway that mediates the GDNF-BDNF axis in FAPs by incorporating the methodology suggested by the Reviewer, along with implementation of genetic models such as <italic>Plp1CreER</italic>; <italic>Gdnffl/fl</italic>, <italic>Prrx1Cre</italic>; <italic>Retfl/fl</italic> or <italic>Prrx1Cre</italic>; <italic>Gfra1fl/fl</italic> to validate whether Schwann cell-derived GDNF can actually signal through its canonical receptor RET/GFRÎ±1 expressed in FAPs to induce expression of BDNF upon nerve injury.</p><disp-quote content-type="editor-comment"><p>[4] (a) There is no direct experimental proof that GDNF activating GFRa1-RET signaling triggers BDNF upregulation in FAP cells. Authors can use GDNF blocking antibodies, siRNA or use RET or GFRa1 cKO mice to delete them from FAP cells. (b) The data that GDNF signaling is inducing the synthesis and secretion of BDNF is also not conclusive. Authors should show that GDNF injection is increasing BDNF protein levels in FAPs. To get sufficient material for ELISA detection of BDNF is perhaps problematic. However, authors can use BDNF antibodies from Icosagen company and use IHC.</p></disp-quote><p>- (a) We appreciate the Reviewer for the critical comment. As mentioned in the reply for Reviewer #1 Public review [3], we used GDNF blocking antibodies to reduce GDNF signaling within the tibialis anterior and gastrocnemius muscles by intramuscular injection after sciatic nerve crush injury, and included the result as a new figure supplement in our revised manuscript (New Figure 4âfigure supplement 2) with its details in both the Results section (lines 381-390) and the Materials and Methods section (lines 611-616). Though the results were not statistically significant, intramuscular injection of anti-GDNF antibodies showed a tendency toward reduced <italic>Bdnf</italic> expression in FAPs, compared to IgG controls. As mentioned in the reply for Reviewer #1 Public review [3], and as suggested by the Reviewer, using cKO mice such as <italic>Plp1CreER</italic>; <italic>Gdnffl/fl</italic>, <italic>Prrx1Cre</italic>; <italic>Retfl/fl</italic>, or <italic>Prrx1Cre</italic>; <italic>Gfra1fl/fl</italic> mice would further validate the GDNF-BDNF axis suggested in this study, likely with statistical significance. Unfortunately, obtaining these genetic models within the limited time frame of this current revision is not feasible. We will try to adopt such models in our future study to validate the role of Schwann cell-derived GDNF in inducing BDNF expression in FAPs via activation of RET/GFRÎ±1.</p><p>- (b) We appreciate the Reviewer for the constructive comment. Though we fully agree that the experiment suggested by the Reviewer would validate the synthesis and secretion of BDNF protein by GDNF signaling in FAPs, we were not able to perform it due to lack of research funds to obtain enough amount of the GDNF protein. We hope that the Reviewer understands our limitation. Still, combining the results from New Figure 4H in this study with the New Figure 4F, where GDNF injection induced <italic>Bdnf</italic> mRNA expression in FAPs, and BDNF protein expression in FAPs in response to nerve injury was demonstrated via western blot, we anticipate that GDNF injection would increase BDNF protein levels in FAPs, though direct validation of this statement would require conducting the additional experiments mentioned by the Reviewer.</p><p>References</p><p>Chan JR, Cosgaya JM, Wu YJ, and Shooter EM (2001). Neurotrophins are key mediators of the myelination program in the peripheral nervous system. <italic>Proceedings of the National Academy of Sciences</italic> 98:14661-14668.</p><p>English AW, Liu K, Nicolini JM, Mulligan AM, and Ye K (2013). Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves. <italic>Proc Natl Acad Sci U S A</italic> 110:16217-22.10.1073/pnas.1303646110</p><p>Giordani L, He GJ, Negroni E, Sakai H, Law JY, Siu MM, Wan R, Corneau A, Tajbakhsh S, and Cheung TH (2019). High-dimensional single-cell cartography reveals novel skeletal muscle-resident cell populations. <italic>Molecular Cell</italic> 74:609-621. e6.</p><p>HÃ¶ke A, Gordon T, Zochodne D, and Sulaiman O (2002). A decline in glial cell-linederived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. <italic>Experimental neurology</italic> 173:77-85.</p><p>Kim J-H, Kang J-S, Yoo K, Jeong J, Park I, Park JH, Rhee J, Jeon S, Jo Y-W, and Hann S-H (2022). Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system. <italic>JCI Insight</italic> 7:</p><p>Leinroth AP, Mirando AJ, Rouse D, Kobayahsi Y, Tata PR, Rueckert HE, Liao Y, Long JT, Chakkalakal JV, and Hilton MJ (2022). Identification of distinct non-myogenic skeletal-muscle-resident mesenchymal cell populations. <italic>Cell Reports</italic> 39:</p><p>Liu L, Cheung TH, Charville GW, and Rando TA (2015). Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting. <italic>Nature protocols</italic> 10:1612-1624.</p><p>Oudega M, and Hagg T (1998). Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord. <italic>Brain Research</italic> 818:431-438.10.1016/S0006-8993(98)01314-6</p><p>Xiao J, Wong AW, Willingham MM, Kaasinen SK, Hendry IA, Howitt J, Putz U, Barrett GL, Kilpatrick TJ, and Murray SS (2009). BDNF exerts contrasting effects on peripheral myelination of NGF-dependent and BDNF-dependent DRG neurons. <italic>J Neurosci</italic> 29:4016-22.10.1523/JNEUROSCI.3811-08.2009</p><p>Xu P, Rosen KM, Hedstrom K, Rey O, Guha S, Hart C, and Corfas G (2013). Nerve injury induces glial cell linederived neurotrophic factor (gdnf) expression in schwann cells through purinergic signaling and the pkcpkd pathway. <italic>Glia</italic> 61:1029-1040.</p><p>Zhang JY, Luo XG, Xian CJ, Liu ZH, and Zhou XF (2000). Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents. <italic>European Journal of Neuroscience</italic> 12:4171-4180.10.1111/j.1460-9568.2000.01312.x</p><p>Zheng J, Sun J, Lu X, Zhao P, Li K, and Li L (2016). BDNF promotes the axonal regrowth after sciatic nerve crush through intrinsic neuronal capability upregulation and distal portion protection. <italic>Neuroscience letters</italic> 621:1-8.</p></body></sub-article></article>